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 ABSTRACT 
 
NUMERICAL SIMULATION OF CAPSULE DISSOLUTION IN THE USP 
APPARATUS II 
 
by Jasmine E. Han 
 
The capsule is the second most common type of drug dosage form, yet detailed 
research of capsule dissolution in the USP Apparatus II (a paddle dissolution apparatus 
that mimics the drug dissolution process in an in vivo environment) is not well reported.  
In this work, a mathematical model was developed that incorporates both the dissolution 
of the capsule shell and the slug within the capsule shell.  Capsule shell dissolution was 
modeled with the assumption that the shell undergoes an erosion process only.  The 
capsule slug dissolution model incorporated mass transfer principles, Markov chain 
theory, and the influence of hydrodynamics on capsules dissolution using computational 
fluid dynamics (CFD)-predicted velocity profiles.  To complete the model, the mass 
transfer coefficients (determined experimentally and theoretically) were incorporated.  
The model was validated by statistically comparing the simulated profiles to the 
experimental data using the similarity factor.  In addition, this model can provide insights 
into the dissolution mechanism where a drug product may either disintegrate or erode 
during dissolution testing.  This capsule slug dissolution model has the potential to reduce 
substantially the number of time-consuming physical dissolution experiments and 
maximize the efficiency of process development. 
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 CHAPTER ONE                                                                                    
INTRODUCTION 
 
 
Oral drug delivery is the preferred route to deliver a pharmaceutical drug product 
to the body due to its relative ease of consumption and minimal interference with daily 
activities.  It is preferred also because it is a pain-free process for most patients.  Two of 
the most common oral dosage forms are tablets and capsules, while other oral drug 
products are packaged in sachets or solution forms.  Regardless of the oral dosage form, 
the drug product consists of an active pharmaceutical ingredient (API) and excipient 
materials.  The excipient materials are included in the drug product to serve as binders, 
disintegrants, lubricants, and dissolution enhancers.   
Upon oral administration of the drug product, drug absorption and its subsequent 
bioavailability depend greatly on the solubility and permeability of the API and dosage 
form.  To help predict the in vivo performance of a drug product, an in vitro dissolution 
test is often performed to determine the release and the dissolution profile of the drug 
substance.  A drug dissolution test is also used to “(1) assess the lot-to-lot quality of a 
drug product, (2) guide development of new formulations, and (3) ensure continuing 
product quality and performance after certain changes” [1].  These key testing attributes 
reflect the extensive use of the dissolution test, its importance in the pharmaceutical 
industry, and its continuing role in future drug development and manufacturing 
processes.  A model to predict the drug dissolution profile would be a valuable tool in the 
pharmaceutical drug development process. 
2 
1.1 The Dissolution Apparatus and the Dissolution Test Method 
The dissolution apparatus is an instrument that mimics the drug dissolution 
process in an in vivo environment.  A schematic diagram of a paddle dissolution 
apparatus is presented in Figure 1.  The dissolution apparatus produces flow using an 
assembly that consists of a cylindrical vessel with a hemispherical bottom and a motor 
with a drive shaft and stirrer known as the stirring element.  The liquid volume (usually 
900 mL), the operating temperature (37°C), and the composition of the medium in the 
cylindrical vessel are selected to represent physiological conditions and allow adequate 
sink conditions during dissolution testing.  Under sink conditions, the final drug 
concentration during the test is at a low enough concentration that dissolution is not 
hindered by solubility limits.  The sink condition is usually equal to 3-10 times the 
solubility of the drug in the selected solution.  Some common dissolution media used are 
water, 0.1N HCl, simulated intestinal fluid, and simulated gastric fluid. 
 
 
Figure 1.  Schematic diagram of a dissolution apparatus. 
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Upon the addition of a tablet or a capsule into the dissolution vessel with the 
selected dissolution medium, the stirring element serves to produce consistent 
hydrodynamics from vessel to vessel.  It also allows homogeneous drug distribution in 
the vessel as the drug product dissolves via the diffusion process.  Even though the 
temperature, pH, volume of the dissolution medium, and paddle rotation speed are 
selected to be similar to those in the in vivo environment, dissolution testing has yet to 
completely represent the continuous change of pH, agitation rate and force, and the 
variable amount of fluid present along the gastrointestinal tract.  Therefore, this in vitro 
dissolution experiment should not entirely replace the more expensive in vivo studies. 
Dissolution apparatus and recommended dissolution methods are well 
documented in both the United States Pharmacopeia (USP) and the United States 
Department of Health and Human Services Food and Drug Administration (FDA) 
database.  There are currently four dissolution test apparatus listed on the USP, namely 
Apparatus I (basket apparatus), Apparatus II (paddle apparatus), Apparatus III 
(reciprocating cylinder), and Apparatus IV (flow-through cell).  Among them, the most 
widely adopted apparatus for tablet and capsule dissolution testing are the USP Apparatus 
I and the USP Apparatus II [2].  The main difference between the two is the stirring 
element.  In Apparatus I, flow is produced by a cylindrical basket, whereas, in Apparatus 
II, flow is produced by a “paddle formed from a blade and a shaft” [2].  The 
specifications of the basket and paddle stirring elements, mandated by the USP to ensure 
consistency in testing, can be found in USP Chapter 711 [2].  Should a dosage form (such 
as a capsule) float in the dissolution medium, a sinker device is attached to the tested 
4 
drug product to force the sample to sink to the bottom of the paddle apparatus.  Capsule 
dissolution using a paddle apparatus, one of the most common in vitro dissolution test 
apparatus to predict solid drug product performance in the in vivo environment, is the 
system of interest in this study. 
In addition to the USP specifications, the FDA also heavily regulates dissolution 
testing requirements.  To help ensure that dissolution test methods provide reliable 
information, the FDA’s Center for Drug Evaluation and Research (CDER) provides a list 
of guidance documents for the industry.  Furthermore, the FDA also provides 
recommended dissolution test methods, which include the type of apparatus, speed of the 
stirring element, composition and volume of the medium, and sampling times for all the 
drugs listed in their database [3]. 
1.2 Failures of Dissolution Testing 
Dissolution testing is a critical test in the drug development process.  It is a 
regulatory requirement mandated by the FDA, and the USP has provided strict 
dissolution apparatus specifications.  The USP Apparatus II became an official test 
apparatus in 1978.  However, the hydrodynamics within the dissolution apparatus have 
not been fully understood, and many inconsistent measurements and test failures have 
been reported [4-7].  Variability in dissolution profiles was found even with calibrator 
tablets [5, 8-9].  This suggests that some recalled drug products were a result of faulty 
apparatus configuration.  In a technical report submitted to the FDA, Armenante et al. 
[10] reported that “failed dissolution tests resulted in 47 product recalls in 2000-2002, 
representing 16% of non-manufacturing recalls for oral solid dosage forms.”  Moreover, 
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twenty products were found on the Health Canada recall list in 2009 to 2010 [11-12].  
Drug product recalls due to dissolution test failures are inevitable if the root cause is not 
resolved.  It is vital to determine whether the failures are due to the apparatus 
configuration or to the drug itself. 
Failures of dissolution testing can be a financial burden to pharmaceutical 
companies, as they increase investigation and manufacturing costs.  In addition, 
misleading dissolution data on commercial drug products can be life-threatening to 
patients.  For example, in a study conducted by Barone et al. [13], it was found that 
among the 25 piroxicam capsule brands sold on the international market, 72 percent 
failed to meet the USP dissolution test requirements.  This indicates possible differences 
in the formulations of these capsule brands.  Moreover, these dissolution failures post a 
potential difference in bioavailability and bioequivalence.  Bioavailability is the amount 
of drug that enters systemic circulation.  Bioequivalence is the equivalent drug 
concentrations in blood plasma and tissues when drug products are given to the same 
patient in the same dosage regimen.  Consequently, drug efficacy could be altered.  In the 
case of piroxicam, the difference in bioavailability could result in the rare side effect of 
gastrointestinal bleeding [13, 14].  To maximize patient safety and reduce potential 
financial burden, proper setup of the dissolution test method during the entire product 
development process is critical.        
1.3 Criteria for Success 
A reliable dissolution test method should accurately reveal the performance of a 
drug product.  If the doses or the dissolution rates of two different lots of drug products 
6 
are supposed to be different, then the dissolution test method should be able to 
discriminate between them.  Likewise, the test method should provide consistent 
measurements if the drug products are deemed to be identical.  
In an ideal environment, a dissolution test method is considered to be developed 
once the dissolution medium, the speed of the stirring element, the wavelength to be 
studied, and the sampling time intervals have been identified.  The dissolution medium is 
selected to allow appropriate sink conditions for dissolution to occur, while the stirring 
element helps distribute the drug within the medium and mimics the in vivo 
hydrodynamic environment.  The wavelength is chosen to detect drug concentration in 
the medium, and the sampling time intervals are the specific times when the amount of 
drug dissolved is measured. 
Upon developing a test method, the drug product is randomly dropped into the 
dissolution vessel and its performance appraised.  However, it has been reported that the 
drug product location in the USP Apparatus II dissolution vessel during the test and the 
speed of the stirring element have substantial influence on the hydrodynamics in 
dissolution testing [9, 10, 15-18].  The drug product experiences different shear forces 
and fluid velocities at various locations in the dissolution vessel.  Shear force is important 
in dissolution testing, as it determines the boundary layer for mass transfer of the drug 
substance from the drug product into the surrounding medium.  Lower shear, and hence a 
slower dissolution rate, is found when the drug product is located at the bottom center of 
the vessel [9, 10, 15-18].  Different paddle speeds are found to give rise to different fluid 
flow patterns [9, 10, 15-18].  All these factors shape the dissolution profile and determine 
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the dissolution result.  It is therefore crucial to be able to identify whether the difference 
in dissolution results is due to drug product variations, or if it is caused by the inherent 
hydrodynamic variations within the apparatus.  To set up reliable test methods and 
acquire meaningful results, the hydrodynamics of the dissolution process and the 
interactions between the drug product and the in vitro dissolution medium must be fully 
understood.   
1.4 Hydrodynamics and Numerical Simulation of Capsules Dissolution 
Interest in understanding the hydrodynamics of the dissolution process has grown 
in recent years [9, 10, 16-25].  Several numerical simulations of tablet dissolution in the 
USP Apparatus II dissolution vessel are documented [9, 10, 16-19, 21, 24, 25].  
Computational fluid dynamics (CFD) is adopted to model the hydrodynamics of the 
dissolution apparatus.  For example, the effects of paddle speed, impeller clearance, 
impeller type, vessel geometry, and the position of tablets on the hydrodynamics in the 
dissolution vessel have been studied [9, 10, 15-19, 21].  The resulting velocity flow 
fields, as well as the shear environment, are found to be non-uniform [9, 10, 15-19, 21].  
These non-uniformities lead to fluctuations in the mass transfer rate of the tablet material 
to the medium, thus explaining the substantial dissolution variations. 
Among the 763 drugs in the FDA database for which recommended dissolution 
methods are provided, 506 are given in tablet form while 171 are in capsule form [3].  
The other 86 drugs are in other dosage forms, such as suspension, injection, or 
suppository [3].  Capsules are the second most common type of dosage form.  However, 
detailed research of capsule dissolution in the USP Apparatus II is not well reported.   
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The complex flow field in the dissolution vessel intensifies the need for further 
research.  This study aims to call attention to the influence of hydrodynamics on capsule 
dissolution.  First, a mathematical model that describes the dissolution process via 
erosion and disintegration was established.  The mass transfer coefficient between the 
dosage and medium was determined both experimentally from dissolution data in the 
literature, and theoretically with CFD-predicted data.  The model was then coupled with 
predicted mass transfer coefficients to describe the dissolution of a capsule under 
agitation conditions in a USP Apparatus II dissolution bath.  Numerical simulation of the 
capsule model was conducted using a commercially available numerical computation 
platform (Microsoft Excel™).  Equations that describe the dissolution profile were 
developed and the simulated profile was verified using the capsules dissolution profiles 
from published experimental dissolution data.  This resulted in a computational model 
that describes the capsule dissolution process.  This model can aid in process 
optimization and can maximize process development efficiency by allowing the study of 
a larger sample size in a shorter amount of time (as compared to conducting numerous 
physical dissolution experiments). 
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CHAPTER TWO                                                                                         
LITERATURE REVIEW 
 
 
A good oral drug product is expected to provide both the anticipated therapy and 
consistent efficacy.  Changes in drug substance polymorph (e.g. amorphous or 
crystalline), formulation differences (e.g. excipients properties), process parameters 
variations (e.g. tablet hardness), and drug product stability in various environments (e.g. 
moisture, capsule cross-linking) are some of the factors affecting the effectiveness of the 
final drug product.  Therefore, it is important to identify and to control the source of 
variability before the drug product is released for human consumption.   
By comparing the dissolution profiles of drug products, the existence of any 
source of variability may be identified.  However, many reports in the literature indicated 
that dissolution variations could be caused by the inherent variability of the dissolution 
apparatus itself [5, 6, 8-10, 15-17, 21, 23-27].  Tablet or capsule dissolution occurs via a 
mass transfer process.  The velocity flow field that is created by paddle rotation in the 
vessel affects the mass transfer process.  Therefore, it is important to understand both 
mass transfer and the hydrodynamic conditions in the dissolution apparatus.   
This review covers the brief history and importance of in vitro dissolution testing, 
the mass transfer and hydrodynamic effect on tablet dissolution, and a discussion on 
capsule dissolution.  It ends with a summary of previous work and a discussion of how 
the current research fits into and benefits the study of hydrodynamics in USP dissolution 
test Apparatus II. 
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2.1 History and Importance of Dissolution Testing   
Noyes and Whitney [28] conducted the first dissolution experiment in 1897.  
They suggested that dissolution of materials into the surrounding medium was 
determined in a region where a thin diffusion layer formed around the solid particle.  In 
addition, they showed that the rate of dissolution is proportional to the difference between 
the saturated solubility, Cs, of the substance and the concentration, C, at time t [28].  
Equation 1 presents the statement mathematically, where kN is the proportionality 
constant. 
                                                         
dC
dt
= kN Cs − C( )                                        Equation 1 
In 1904, Nernst and Brunner explained the rate of drug dissolution as a function 
of the diffusion coefficient, DAB, the surface area, A, the diffusion layer thickness, h, the 
dissolution medium volume, VL, and the concentration difference.  The Nernst-Brunner 
equation is presented in Equation 2 [7, 29]. 
                                                       
dC
dt
=
DAB A
VLh
Cs − C( )                                      Equation 2 
  It was not until the 1970s that dissolution experiments of pharmaceutical drug 
products became an official test in the USP.  Since then, the USP Apparatus II has been 
the most common apparatus for solid drug product testing [4, 29].  Dissolution testing has 
become a regulatory requirement mandated by the FDA.  It is required both for the 
submission of new drug applications (NDAs) for new chemical entities, and for 
abbreviated new drug applications (ANDAs) for generic products.  It is also required for 
assuring a product’s sameness after scale-up or post-approval changes and for waiving 
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the bioequivalence requirements for lower strengths of a drug product [1].  There is no 
doubt that dissolution testing plays a very important role in the drug development 
process, and the information it provides can be critical to the success or failure of a drug 
product.  
There are several reasons that make dissolution testing a prevailing tool and a 
primary choice in formulation development.  First and foremost, the dissolution test is the 
only in vitro test that can help predict in vivo performance of a drug product [30].  In 
simpler terms, it allows drug development scientists to find out if a drug product can 
dissolve and be bioavailable in the patient.  The test is conducted isothermally at body 
temperature (37°C) and the dissolution medium is prepared to have a similar pH to the 
pH of the gastro-intestinal tract.  If a drug is to be absorbed mainly in the stomach, a 
dissolution medium of pH 1.2 should be used, whereas if it is to be absorbed mainly in 
the intestine, the pH of the dissolution medium should be 6.8.  The use of surfactant or 
dissolution medium at other pHs (in the range of 1.2 to 8.0) is sometimes employed upon 
proper justifications [1].  Some other dissolution testing conditions include the use of 900 
mL of dissolution medium to allow adequate sink conditions, and the use of paddle 
rotation to ensure proper mixing between the “drug-saturated layer of dissolution from 
around the dosage” and the surrounding medium with a lower drug concentration [30]. 
With such a critical role in the drug development process, dissolution testing is 
governed and regulated by both the USP and FDA [1, 2, 3, 30].  The dissolution chapter 
in the USP has been harmonized internationally with the European Pharmacopoeia and 
the Japanese Pharmacopoeia [2, 30].  Specifications and tolerances of the dissolution 
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apparatus are defined and documented in the USP chapter 711 [2].  In addition, the USP 
describes the use of performance verification tests to determine the suitability of a test 
assembly, the procedures to conduct dissolution tests for various dosage forms 
(immediate-release, extended-release, and delayed-released), and the acceptance criteria 
for dissolution test results [2].  On the other hand, the FDA “reviews the USP monograph 
dissolution tests for consistency with the dissolution conditions in the approved product’s 
New Drug Application” [30].  It also provides a list of guidance documents for the 
industry.   
2.2 Mass Transfer and Hydrodynamic Effects on Tablet Dissolution 
Tablet dissolution is a mass transfer process, wherein a solid mass (comprised of 
the active pharmaceutical ingredient compacted together with pharmaceutical excipients) 
starts dissolving into the surrounding medium via an erosion or disintegration 
mechanism.  Tablet mass transfer by molecular diffusion alone would be an extremely 
slow process.  To enhance the mass transfer rate and to ensure proper mixing within the 
liquid, a paddle rotating at a designated speed is applied during dissolution testing.  It is 
generally assumed that mixing is uniform.  However, the fluid velocity distribution in the 
system, generated from the rotating paddle, may not necessarily be homogeneous.  
Numerous reports have suggested that the complex hydrodynamics of the dissolution 
Apparatus II is attributed to the high variability in dissolution test results [9, 10, 15-19, 
21, 23-27, 31].  This section reviews the studies conducted through experiments and 
numerical simulations of fluid motion to understand the mass transfer process and the 
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hydrodynamics of fluid flow within the dissolution Apparatus II.  The effect of 
hydrodynamics within the vessel on tablet dissolution is also discussed.   
2.2.1 Mass Transfer 
When a solid tablet is dropped into a liquid dissolution medium, diffusion and 
mass transfer from the solid to the surrounding liquid take place.  This mass transfer 
process can be described by Equation 3, where C is the drug concentration in the 
dissolution medium at time t, Cs is the saturated concentration of the drug, k is the mass 
transfer coefficient, A is the surface area of the solid dosage, and VL is the volume of the 
dissolution medium [17].  Equation 3 shows that the rate of drug dissolution is directly 
proportional to the mass transfer coefficient, tablet surface area, and the concentration 
gradient. 
                                                         
dC
dt
=
kA
VL
Cs − C( )                                       Equation 3 
Throughout the tablet dissolution process, a diffusion boundary layer forms 
around the tablet.  As shown in Equation 2, the dissolution rate is inversely proportional 
to the thickness of the diffusion layer.  The thicker the diffusion boundary layer, the 
slower the mass transfer process.  Consequently, the dissolution rate becomes slower.  
Since the shear force exerted by the fluid can affect the thickness of the boundary layer at 
the surface of the tablet, any shear rate variation within the dissolution medium can 
greatly affect the dissolution results [19].  In addition, mass transfer is proportional to the 
velocity gradient in the boundary layer and the corresponding local strain rate.  
Therefore, a high strain rate will result in a more rapid dissolution rate.  A detailed 
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understanding of the velocity and strain rate distributions within the vessel fluid is 
essential to fully evaluate the dissolution process.   
2.2.2 Hydrodynamics and Computational Fluid Dynamics 
Interest in using CFD to predict fluid motion in a system has grown in recent 
years.  CFD is used to predict velocity, energy, and strain rate patterns.  It is also used to 
provide a visual description of the hydrodynamics of a system through the interpretation 
of numerical data, using appropriate graphing routines.  Numerical simulations enable the 
study of systems where it is impossible or very challenging to measure these values 
quantitatively via experimental methods.  In addition, CFD allows for faster and less 
expensive simulation of experiments.  In studying the hydrodynamics of tablet 
dissolution, many researchers have adopted this technique to simulate the fluid flow 
conditions inside the vessel [9, 16-25, 27, 31, 32]. 
The CFD simulation of fluid flow conditions in the USP Apparatus involves 
solving the governing equations that describe fluid motion.  According to the set-up of 
the apparatus, cylindrical coordinates are used to model the system.  These include the 
continuity equation and the Navier-Stokes equations, which are presented in Equations 4 
and 5, respectively [25, 33, 34].  The continuity equation is a mathematical expression of 
the conservation of mass that describes the time rate of change of fluid density at a 
certain point in space.  Assuming the dissolution medium is incompressible, the time rate 
of change of fluid density equals zero.  The Navier-Stokes equations refer to the 
conservation of momentum.  Since the dissolution testing is conducted isothermally at 
37°C, the energy equations are not included in this study. 
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( ) 0=⋅∇+
∂
∂
vρ
ρ
t
                                         Equation 4        
                                                  
  
ρ
Dv
Dt
= −∇p + µ∇2v + ρg                                    Equation 5 
The first term of the continuity equation in Equation 4 describes the rate of 
change of mass per unit volume, while the second term describes the net rate of change of 
mass per unit volume, and the sum of these terms should equal to zero.  For dissolution 
study, it is assumed that there is no reaction between the drug product and dissolution 
medium.  Therefore, no reaction term is required.  In this continuity equation, ρ is the 
density of the fluid, t is time, and v represents the velocity vector with components vr, vθ, 
and vz in the radial, tangential, and axial directions, respectively.  As presented in 
Equation 5, the conservation of momentum includes convective transport, molecular 
transport, and external force such as gravitational force.  These are described by the term 
on the left, the first and second terms on the right, and the third term on the right of the 
equation, respectively.  This Navier-Stokes equation is presented in material derivation 
form, where v represents the velocity vector with the components vr, vθ, and vz, p is the 
fluid pressure, µ is the dynamic fluid viscosity, and g is the gravitational acceleration 
vector. 
In addition to the governing equations, dimensionless parameters such as 
Reynolds number are often used to characterize fluid flow.  As presented in Equation 6, 
Reynolds number, Re, is the ratio of inertial to frictional forces in a fluid system, where ρ 
is the fluid density, N is the rotational speed of the agitator, d is the agitator diameter, and 
µ is the dynamic fluid viscosity [9, 23, 31, 34].  Fluid flow can be categorized into three 
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different regimes: a laminar regime as indicated by a small Reynolds number, a turbulent 
regime with a large Reynolds number, and a transitional regime that is between the 
laminar and turbulent regimes.  In the case of mixing tanks, the transitional regime is 
characterized by Reynolds numbers between 50 and 5000 [34].   
                                                            
Re =
ρNd2
µ
                                            Equation 6 
According to the FDA industry guidelines, dissolution testing using the Apparatus 
II should be conducted under mild (non-fully turbulent) conditions, with a paddle rotation 
speed of 50 rpm or 75 rpm [1].  Bai et al. [24] mentioned that at a low impeller Reynolds 
number of 4939 with a corresponding agitation speed of 50 rpm, most of the fluid in the 
vessel is in a transitional domain.  Similarly, Kukura et al. [31] show that under standard 
operating conditions where the Reynolds number is approximately equal to 5000, the 
flow within the Apparatus II is in a transitional turbulence regime.  This transitional 
regime creates an unstable environment that makes the flow behavior of the fluid in the 
vessel and around the tablets highly time-dependent [23, 31].  The substantial variation in 
hydrodynamics of the Apparatus II could therefore be attributed to the Reynolds number, 
a characteristic of the flow field during dissolution testing. 
According to the literature, to model the fluid velocity in the dissolution vessel 
using CFD, the flow volume is first discretized into a mesh of finite elements where the 
velocity for each node was solved using the governing equations [9, 16, 17, 19, 21, 23, 
24].  Due to the geometry of the dissolution vessel, the cylindrical portion of the vessel 
was meshed with hex cells, while the lower hemispherical portion of the vessel was 
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meshed with unstructured tetrahedral cells [17, 24].  These meshes were further refined 
until the simulation converged to a stable solution.  Having the impeller rotated at 50 
rpm, Bai et al. [17, 21, 24] showed that the k-ω model with a low Reynolds number 
correction was a better turbulence model to predict the fluid velocity than other models.  
This was confirmed by comparing the CFD predicted values to the experimental velocity 
data obtained via laser-doppler velocimetry [24].  Baxter et al. [9, 19] and Kukura et al. 
[16, 23], however, incorporated the Reynolds-averaged Navier-Stokes (RANS) equation 
to the CFD model and treated the fluid flow in the turbulent regime. 
While constructing the mathematical model, a no-slip condition was assumed at 
all solid surfaces [17, 21, 24].  In addition, the air-water interface was modeled as a flat 
frictionless surface.  The normal gradients of all the variables are therefore equal to zero 
at the air-water interface.  In the model developed by Bai et al. [17, 21, 24], the vessel 
wall and the tablet were assumed to be rotating, while the impeller was set as stationary.  
The result of this simulation using the CFD solver (Fluent) showed the 3-dimensional 
velocity and strain rate distributions within the dissolution vessel. 
After the CFD solver generates the velocity or strain rate data for the selected 
flow field, the information is compared to the experimental data to validate the model.  
Figure 2 presents the velocity field pattern inside the dissolution apparatus at 50 rpm.  
The velocity field pattern shows two recirculation loops, one above and one below the 
impeller [9, 16, 21].  For the loop above the impeller, fluid is ejected up the vessel wall 
from the impeller.  Upon reaching the surface of the liquid, the fluid moves down along a 
path that is located between the shaft and the wall.  For the loop below the impeller, fluid 
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moves down along the vessel wall towards the base of the vessel, and moves back up 
towards the bottom of the impeller.  The velocity flow field predicted by Bai et al. [17, 
21, 24] showed that the recirculation loop was not able to penetrate a core region along 
the vessel base below the impeller. 
 
Figure 2.  Velocity field pattern inside Apparatus II at 50 rpm. 
  
The velocity pattern inside the Apparatus II appears to be highly heterogeneous.  
Velocity decays rapidly as it moves away from the impeller blades [21].  A review of the 
hydrodynamic conditions reported by various researchers showed that there is generally a 
low velocity region below the center of the paddle, where the solid dosage is likely to be 
located [20, 21, 24, 25, 27].  Figure 3 presents the velocity flow field in the vessel with 
the presence of a tablet [35].  The figure shows that the velocity around the tablet is a lot 
lower compared to the non-centrally located positions.  D’Arcy et al. [20] modeled the 
paddle apparatus and found that when the paddle rotates at 50 rpm, the velocity of the 
fluid within 12 mm of the center at the base of the vessel was about 0.8 x 10-3 m/s.  
However, velocity had a much wider range throughout the base of the vessel, which 
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varied from 0.8 x 10-3 to 79.6 x 10-3 m/s.  In another study conducted by D’Arcy et al. 
[27], the dissolution rate was found to agree with the CFD data, where both dissolution 
rate and velocity increased significantly when the solid dosage was moved from the 
center of the vessel to 13 mm away from the center.  Bai et al. [21] also found that the 
velocity of a 10-mm-wide region between the bottom center of the impeller and the 
bottom center of the vessel is less than 5% of the impeller tip speed.  This region 
accounted for the lowest fluid velocity region within the entire vessel [21, 24].  Indicated 
both numerically by CFD simulation and experimentally by laser-doppler velocimetry, 
the flow in this region is mainly dominated by weak tangential velocities (velocity 
component in the direction of paddle rotation) and is nearly stagnant in the vertical plane 
[24].   
Similarly, McCarthy et al. [25] found that the velocity distribution within the 
vessel was highly variable.  The authors showed that the region below the center of the 
impeller contained a low velocity domain, and the fluid velocity at the base of the vessel 
where the solid dosage is likely to be located varied significantly within regions that were 
8 to 10 mm apart.  These results explain the variations often observed in dissolution 
testing.  In addition, they correlate well with other work cited in the literature, which 
show that slight differences in the position of a tablet during dissolution testing can lead 
to substantial variation in dissolution results [9, 10, 15-17, 27]. 
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Figure 3.  Velocity flow field inside a paddle apparatus with a tablet [35] (reprinted with 
permission from O. Akiti). 
 
Some researchers further evaluate the magnitude of the tangential velocity as a 
function of radial position in the region below the paddle [24, 25].  The tangential 
velocity component of the velocity was predominant, compared to the axial and radial 
components throughout the vessel [24, 25].  Figure 4 presents the cylindrical velocity 
components.  Bai et al. [24] showed that in the region below the impeller, the tangential 
velocity increased radially to a peak velocity before its magnitude reduced again as it 
approached the vessel wall.  Compared to the region above the impeller, the peak 
tangential velocity was closer to the wall when it was below the impeller, although the 
velocity eventually decayed in both regions.  McCarthy et al. [25] also studied the 
tangential velocities that are 5.3 mm from the base of the vessel at a paddle speed of 50 
rpm.  Similar to Bai et al. [24], they found that the tangential velocity increased as the 
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radius increased from about 5 mm to 17 mm, although tangential velocity at a radius 
beyond 20 mm was not measured. 
 
Figure 4.  Cylindrical velocity components. 
 
Bai et al. [24] graphically presented CFD-predicted tangential velocity profiles on 
different iso-surfaces, or horizontal planes, located at various vertical positions along the 
height of the vessel when the paddle rotated at a speed of 50 rpm (corresponding to 0.194 
m/s impeller tip speed).  The computation approach to determine tangential velocities 
from the graphs generated by Bai et al. [24] can be found in Appendix A.  The resulting 
computed tangential velocities on various iso-surface planes below the paddle, together 
with the corresponding distance from the bottom of the vessel, are tabulated in Table 1.  
Note that the tangential velocities presented in Table 1 correspond to a radial distance of 
approximately 5 mm to 10 mm from the center of the impeller, equivalent to a 10 mm to 
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20 mm diameter circle (as shown in Figure 5) where a solid dosage is most likely to be 
located.  To help visualize the various locations of iso-surface plane, Figure 5 also 
presents the relative distances between the bottom of the paddle and the bottom of the 
vessel. 
Table 1.  Tangential velocity at various distances from the bottom of the vessel (5 to 10 
mm from the center of the impeller) [24]. 
 
Distance from vessel bottom (mm) vθ  (m/s) 
19.05 ~ 0.029 – 0.058 
13.05 ~ 0.031 – 0.058 
7.05 ~ 0.029 – 0.056 
 
 
Figure 5.  Radial distance from the shaft and various locations of the iso-surface plane. 
 
To compare the tangential velocities obtained by Bai et al. [24] and McCarthy et 
al. [25], the radial distances and tangential velocities presented in Table 2 are estimated 
from graphical data presented by McCarthy et al. [25].  Similarly, the computational 
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approach towards obtaining the tangential velocities from McCarthy et al. [25] can be 
found in Appendix A.  Tangential velocities estimated from both sources (as shown in 
Tables 1 and 2) compare well at a radial distance of about 5 mm to 10 mm.  Table 3 
presents the CFD-predicted velocity vectors, which consist of the radial, tangential, and 
axial velocity components, around the tablet surface location from the literature reviewed 
in this section.  The tangential velocities calculated in both Tables 1 and 2 are within the 
same order of magnitude as the CFD-predicted velocity vectors in Table 3, indicating that 
the tangential velocity plays a major role in predicting CFD velocity [24, 25]. 
Table 2.  Tangential velocity at various radial distances from the center of the shaft (5.3 
mm from the base of the vessel) [25]. 
 
r (mm) vθ  (m/s) 
4.78 0.029 
8.99 0.049 
13.31 0.069 
17.48 0.088 
 
Table 3.  CFD-predicted velocity vectors around the tablet surface location. 
 
Description CFD-predicted 
velocity vectors (m/s) 
Ref. 
No tablet 
~ 0.03 – 0.06 [17] 
~ 0.01 – 0.04 [21] 
~ 0.01 – 0.05 [24] 
Centrally located tablet (erosion) ~ 0.04 – 0.06 [17] 
Centrally located tablet (disintegration) ~ 0.03 – 0.06 [17] 
Centrally located tablet ~ 0.012 – 0.024 [27] 
 
 In addition to predicting velocity profiles and estimating the tangential velocity 
using CFD, Bai et al. [17] further utilized the CFD-predicted tangential velocity to 
computationally determine the mass transfer coefficient for a centrally located non-
disintegrating salicylic acid tablet.  First, the mass transfer coefficients for both the top 
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surface and the side of a tablet were estimated.  Assuming that the mass transfer process 
at the top of the surface resembles that of a rotating disk, while the mass transfer process 
on the side of the tablet is similar to that of a rotating cylinder surrounded by fluid, the 
mass transfer coefficients for these two locations can be described by Equations 7 and 8 
[17, 36, 37].  Here, ktop is the mass transfer coefficient on the top of the tablet, DAB is the 
diffusivity or diffusion coefficient between the solute and the solvent, ν is the kinematic 
viscosity of the liquid, ω is the angular velocity of the rotating disk, kside is the mass 
transfer coefficient on the side of the tablet, dT is the diameter of the tablet, ReΩ is the 
rotating Reynolds number, and Sc is the Schmidt number.  The overall theoretical mass 
transfer coefficient for the entire tablet can then be estimated according to Equation 9, 
where Atop and Aside refer to the surface area of the top and the side of the tablet, 
respectively [17].  Dissolution of tablets was also conducted to calculate the mass transfer 
coefficient experimentally by integrating the mass transfer equation presented in 
Equation 3.  The theoretically predicted mass transfer coefficient was found to correlate 
well with the experimental mass transfer coefficient.  In addition, mass transfer 
coefficients for tablets located at various off-centered positions were also estimated and 
the resulting values were found to agree with the CFD-predicted strain rate as well as the 
dissolution results. 
                                                   ktop = 0.62DAB
2 / 3ν −1/ 6ω1/ 2                                   Equation 7 
                                               
ksidedT
DAB
= 0.135 0.5ReΩ
2 Sc[ ]1/ 3                               Equation 8 
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k =
ktop Atop + ksideAside
Atop + Aside
                                    Equation 9 
Strain rate is another valuable piece of information predicted by CFD to help 
understand the hydrodynamic conditions within the dissolution vessel.  A high strain rate 
environment corresponds to faster drug product dissolution, while a low strain rate gives 
a slower dissolution profile.  To find out the strain rate distribution, Baxter et al. and 
Kukura et al. [9, 16] developed a model for the Apparatus II operated at both 50 rpm 
(Reynolds number of 4688) and 100 rpm (Reynolds number of 9375).  The model shows 
that the spatial distribution of shear rates within the vessel is substantially heterogeneous.  
A low-shear region is identified at the bottom center of the vessel (where a tablet will be 
located), while a two-fold increase in shear force is found 21 mm from the center.  
Experiments where the physical locations of the tablets are controlled showed the 
substantial variability in dissolution rates.  The two-fold increase in shear force on the 
tablet, with respect to the location of the tablets in the vessel, was also found to affect the 
corresponding dissolution rate.  These results confirm the heterogeneous shear 
environment as revealed by the model.  Bai et al. [21], who found that a 10-mm-wide 
core (located below the impeller shaft) with low strain rates was surrounded by a region 
of high strain rates, also showed that the strain rate distribution is highly heterogeneous 
along the bottom of the vessel.  In addition, Bai et al. [17] showed the strain rate variation 
through CFD simulation and dissolution studies.  The authors showed that the centrally 
located tablets had both the slowest dissolution profiles and the lowest strain rate on their 
surfaces, which agrees with the prediction of the CFD model. 
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The literature review showed that both the mass transfer process and the 
hydrodynamic conditions within the dissolution medium govern the dissolution of a solid 
dosage.  CFD simulation shows that both the velocity and strain rate distributions within 
the USP Apparatus II are highly heterogeneous, with a region of low velocity and low 
strain rate below the paddle [9, 16, 17, 20, 21, 24, 25, 27].  In addition, the pronounced 
changes in velocity magnitude over short distances, especially near the vessel base where 
tablets are likely to be located during dissolution tests, may contribute to the variability 
found in dissolution testing [9, 10, 15-17, 27].  Finally, it has been shown that 
information generated by CFD not only correlates with experimental results, the data 
obtained can also be used to determine tablet mass transfer coefficient data [17]. 
2.3 Capsule Dissolution 
The hydrodynamic environment within the dissolution Apparatus II described in 
Section 2.2 was evaluated either with a tablet or without any pharmaceutical dosage 
form.  Although not much attention has been paid to the effect of hydrodynamics on 
capsule dissolution, this should not undermine the importance of capsules in delivering 
pharmaceutical drug substances.  
The capsule is the second most popular type of pharmaceutical dosage form.  It 
allows convenient, direct filling of powdered materials and provides taste masking.  
Unlike a tablet, which is a one-piece solid dosage form, pharmaceutical substances 
delivered in capsules consist of two separable parts: the capsule shell and the filling.  
Depending on the filling inside the capsule, the manufacturing process of a capsule drug 
product can be much simpler than that of a tablet drug product.  However, owing to the 
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ability of capsules to encapsulate a variety of substances such as powders, granules, 
pellets, slugs, tablets, semi-solids, liquids, or even a combination of these materials, 
capsule dissolution can be more complex than tablet dissolution.  Usually, hard capsules 
are used to encapsulate solid materials while soft capsules are used for liquids or semi-
solids [38].  However, hard capsules are occasionally filled with liquids as well. 
There are three common types of hard capsule shell materials used in practice: 
gelatin, hydroxypropyl methylcellulose, and gelatin/polyethylene glycol [39, 40].  
Among them, gelatin has the longest history in hard capsule shell manufacturing due to 
its use in the food industry.  Gelatin is soluble in biological fluids and it forms films very 
easily.  However, it also possesses some undesirable properties, such as brittleness and 
cross-linking formation when the shell is exposed to hygroscopic materials or materials 
with aldehyde groups [39, 41].  Gelatin, water, and coloring agents are the ingredients 
used in forming hard gelatin capsules.   
A capsule itself consists of two portions: the longer part is called the capsule body 
and the shorter part is called the capsule cap.  Hard gelatin capsules are available in a 
variety of sizes that can range from size 000 (largest) to size 5 (smallest) [42].  The size 
of the capsule chosen depends on the amount and the density of materials it needs to 
hold.  Table 4 presents the capacities and dimensions of size 0 and size 1 capsules, which 
are commonly used in pharmaceutical products.  Based on the external diameters of the 
capsule, the thickness of the capsule shell is probably less than or around 0.15 mm.  
Figure 6 presents the exterior view of a capsule shell as well as the interior (filled with a 
slug) before and after the cap is snapped shut. 
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Table 4.  Capacities and dimensions of size 0 and size 1 capsules [42]. 
 
Size 0 1 
Capacity—volume (mL) 0.68 0.50 
Capsule body length (mm) 18.44 ± 0.46 16.61 ± 0.46 
Capsule cap length (mm) 10.72 ± 0.46 9.78 ± 0.46 
External body diameter (mm) 7.34 ± 0.06 6.63 ± 0.06 
External cap diameter (mm) 7.64 ± 0.06 6.91 ± 0.06 
Overall closed length (mm) 21.7 ± 0.3 19.4 ± 0.3 
 
 
Figure 6.  Different views of a capsule (left: exterior; middle: interior; right: interior after 
cap is snapped shut). 
 
To understand the process of capsule dissolution where a drug is being released 
from the capsule, capsule shell dissolution needs to be addressed.  During capsule shell 
dissolution, tiny holes form and grow into openings big enough to release the 
encapsulated materials into the dissolution medium.  Chiwele et al. [39] studied the shell 
dissolution time for several types of sizes 0 and 3 hard capsules.  They found that for hard 
gelatin capsules, the shoulder of the round ends, which are the weakest points of the 
capsules, dissolved first.  In addition, at 37°C, gelatin capsule shells dissolved within 300 
seconds in all the dissolution media (water, hydrochloric acid, phosphate buffer, artificial 
gastric juice, or artificial intestinal juice) investigated in their studies.  El-Malah et al. 
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[41] conducted a similar study to determine the hard gelatin capsule shell rupture time for 
sizes 00, 0, 1, and 3 capsules.  They found that the hard gelatin capsule shell took about 
1.1 minutes to 2.1 minutes before the fill materials inside the capsule were released into 
the dissolution medium (simulated gastric fluid, simulated intestinal fluid). 
It might appear that the capsule shell needs to be completely dissolved before 
drug dissolution takes place.  However, these two processes, shell dissolution and drug 
dissolution, in fact overlap each other [39-41].  Upon the formation of a tiny hole on the 
capsule shell, the mass transfer process between the drug and the surrounding medium 
begins.  Water is drawn into the capsule body while the encapsulated materials (drug and 
excipients) are continuously released.   
Melia et al. [38, 43] stated that the drug is released from the capsule via two main 
processes: disintegration and dissolution.  They described disintegration as “the rapid 
fragmentation of the dosage form under the action of the disintegrant” [38].  
Disintegration reduces the size of the material by breaking it into smaller portions.  
Dissolution, on the other hand, refers to the process where a solid dissolves into a liquid.  
The disintegration process usually completes before the dissolution process, although the 
two processes take place simultaneously at the beginning of the dissolution process [38, 
44].  While drug dissolution is mainly driven by the disintegration process, in some cases 
where the encapsulated materials do not disintegrate, drug dissolution can be driven by an 
erosion process that is similar to the non-disintegrating tablets [17].  This implies that the 
encapsulated material reduces in size because of material wearing from the surface.  The 
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drug release process from a capsule dosage form where a slug is the encapsulated 
material is summarized in Figure 7 as a schematic diagram. 
 
Figure 7.  Drug release process from capsule dosage form.   
 
In general, capsule dissolution (drug release process) refers to the capsule shell 
dissolution and the filling contents (drug) dissolution through the disintegration or 
erosion process.  However, as stated earlier, detailed research of capsule dissolution with 
the hydrodynamic effect in the dissolution Apparatus II is not well reported.  
Consequently, it was the intention of this research to study capsule dissolution by 
incorporating some of the materials that are already examined in the literature for tablet 
dissolution.  
2.4 Summary of Literature Review 
In summary, the heterogeneous hydrodynamic environment within the USP 
Apparatus II has been reported by numerous researchers [9, 16, 17, 20, 21, 24, 25, 27].  
Also, CFD simulations of Apparatus II with and without tablets were presented, along 
with the corresponding hydrodynamic effect on tablet dissolution [9, 16, 17, 20, 21, 24, 
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25, 27].  These studies, however, did not evaluate the capsule dissolution process in the 
USP Apparatus II.  More specifically, the previous work did not establish a mathematical 
expression to predict capsule dissolution.   
Therefore, one of the goals of this work is to predict the mass transfer coefficient 
of a slug inside the capsule theoretically as well as from existing experimental data.  The 
CFD-predicted tangential velocity within the dissolution vessel and the predicted mass 
transfer coefficients were then used to build a model describing the capsule dissolution 
process via commercially available numerical software.   
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CHAPTER THREE                                                                                  
RESEARCH HYPOTHESIS AND OBJECTIVES 
 
 
Previously, it was reported that the hydrodynamic field within the USP Apparatus 
II was highly heterogeneous.  CFD simulations revealed that there was a low velocity 
region at the vessel bottom, where a tablet was likely to be located.  Additionally, the 
tablet mass transfer coefficient predicted from experimental results correlated well with 
the theoretical mass transfer coefficient estimated from CFD-predicted tangential 
velocity.  These studies, however, did not evaluate the dissolution process when capsule, 
the second most common type of drug dosage form, is considered. 
The hypotheses of this study were: 
1. The capsule slug mass transfer coefficient could be predicted in a manner 
analogous to the tablet mass transfer coefficient, using a previously 
determined CFD-predicted tangential velocity.   
2. The experimental and theoretical predicted capsule slug mass transfer 
coefficients could be used in a computational capsule dissolution model 
to generate a dissolution profile that would be statistically similar to the 
published experimental dissolution results. 
The primary objective of this research was to develop a mathematical model that 
incorporates mass transfer principles and hydrodynamic effects when describing the 
capsule dissolution process.  This included capsule shell erosion, slug erosion, and slug 
disintegration.  The secondary objective was to determine if the theoretically predicted 
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mass transfer coefficient for the capsule slug using the CFD-predicted tangential velocity 
correlated with the mass transfer coefficient predicted from experimental data.  Finally, 
this research aimed to determine if the theoretical and experimental mass transfer 
coefficients could be incorporated into the capsule model to numerically simulate 
dissolution profiles that are statistically similar to the published data. 
Since the CFD-predicted velocity vectors around the tablet surface location were 
similar with or without a tablet in the vessel, the hydrodynamic effects on a tablet should 
be similar to that on a capsule.  Therefore, the CFD-predicted tangential velocity can be 
used to determine the theoretical mass transfer coefficient for a capsule.  This embeds the 
hydrodynamic effects on a capsule within the mass transfer coefficient.  In addition, the 
mass transfer coefficient directly affects the dissolution profile.  Therefore, the simulated 
profiles were statistically compared to the published data to determine the validity of both 
the model and the value of the mass transfer coefficient. 
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CHAPTER FOUR                                                                                        
MODEL DEVELOPMENT 
 
 
The goal of this project was to develop a mathematical model that describes the 
capsule dissolution process in the USP Dissolution Apparatus II using basic mass transfer 
principles with the incorporation of vessel hydrodynamics.  This involved the 
development of a mathematical model to describe the capsule dissolution process, the 
estimation of the mass transfer coefficient to determine the rate of material transfer from 
the capsule into the bulk fluid, and the numerical simulation of the capsule dissolution 
profiles.  The simulated profiles were then compared with published experimental data to 
validate the model.  The overall model development process is presented as a flow chart 
in Figure 8. 
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Figure 8.  Flow diagram for capsule dissolution profile model development.  
  
As shown in Figure 8, a mathematical model was first developed using basic mass 
transfer principles.  The model describes the capsule shell erosion, slug erosion, and slug 
disintegration processes.  The mass transfer coefficient was determined both 
experimentally and theoretically.  The experimental mass transfer coefficient was 
estimated using experimental data published in the literature, while the theoretical mass 
transfer coefficient was calculated from CFD-predicted tangential velocity data.  These 
mass transfer coefficients were incorporated into the mathematical model to numerically 
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simulate the capsule dissolution profile.  The model was validated by testing it with three 
extreme dissolution scenarios.  These scenarios are the pure erosion process, the fast 
disintegration process, and the pure disintegration process without diffusion.  The validity 
of the model was further evaluated by comparing the simulated dissolution profile with 
published experimental dissolution profile data.  The goodness of fit between the model 
and the experimental data was assessed statistically by the similarity factor.  
4.1 Mathematical Model Development 
A mathematical expression that models the capsule dissolution process should 
describe the mass transfer processes of both the capsule shell and the material that resides 
within the capsule.  The model in this research was based on modeling the capsule 
contents as a slug inside a hard gelatin capsule.  This model was specifically developed 
for a slug of ascorbic acid with 0.5% magnesium stearate inside a size 1 hard gelatin 
capsule dissolving in a USP dissolution Apparatus II at 50 rpm in 1000 mL 0.1 N HCl at 
37°C.  The dissolution experiment data used to assess the model validity were obtained 
from the work conducted by Heda et al. [45]. 
A slug is a lightly tamped mass of solid material.  To form a slug, the drug 
substance or material blend is machine-tamped into a cylindrical mass.  The resulting 
mass of material resembles a tablet.  It is less compacted and has lower hardness than a 
traditional pharmaceutical tablet.  Since the slug resides inside the capsule, its dimensions 
cannot be larger than the selected capsule size.  More precisely, the slug must be shorter 
than the length of the capsule body for the capsule cap to be snapped shut.  In this study, 
it was assumed that the capsule body was completely filled with the slug material.  
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Therefore, the length of the slug was equal to 16.46 mm, while the diameter was equal to 
6.3 mm.  These dimensions were determined by subtracting the thickness of the capsule 
shell from the dimensions of the capsule body. 
Since the capsule dissolution process involves the dissolution of both the capsule 
shell and the slug it contains, the model was divided into two parts to properly describe 
both dissolution processes.  The capsule shell dissolution was modeled as an erosion 
process.  The mass transfer process for the slug, on the other hand, was modeled in two 
ways—as a disintegration process and as an erosion process.  Both of these processes 
were evaluated when developing the mathematical model, and then compared to 
determine which process better described the slug dissolution process.  Additionally, the 
mathematical model assumed that the capsule shell dissolution and slug dissolution 
occurred in a sequential fashion.   
4.1.1 Slug Dissolution Model Development 
During the slug dissolution process, mass transfer from the solid drug to the 
surrounding fluid occurs across a thin layer known as the diffusion layer.  The thicker the 
diffusion layer, the slower the mass transfer or dissolution process.  Each system has its 
own distinct diffusion coefficient that drives the rate of mass transfer.  The diffusion 
coefficient, DAB, or diffusivity, is a function of the properties of the fluid (molecular 
weight, M, viscosity, µ, association parameter, ψB), the molar volume, VA, of the solute 
at its normal boiling point, and the temperature, TK, of the system.  Equation 10 describes 
the Wilke-Chang diffusivity correlation for estimating the mass transfer coefficient [46]. 
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DAB = 7.4 ×10
−8 ψB MTK
µVA
0.6                               Equation 10 
In addition to the thickness of the diffusion layer and diffusivity, the rate of mass 
transfer is also affected by the concentration gradient across the diffusion layer and the 
surface area of the slug.  This is described by Equation 11, where m is the mass of the 
drug diffused into the fluid and A is the surface area of the slug.  Since the volume of the 
fluid (dissolution medium) remains constant throughout the test, applying the law of 
conservation of mass to the system results in Equation 12 [47].  Combining Equations 11 
and 12, the Nernst-Brunner equation (that was presented by Equation 2 in Section 2.1) is 
obtained.  The mass transfer coefficient, k, represents the thickness of the diffusion layer 
and diffusivity terms in Equation 2, and, when substituted into Equation 2 in Section 2.1, 
results in Equation 3 in Section 2.2. 
                                                       
dm
dt
=
DAB
h
A Cs − C( )                                  Equation 11 
                                                            
dC
dt
=
1
VL
dm
dt
                                          Equation 12 
To obtain an equation that describes the concentration of drug as a function of 
time, Equation 3 is integrated by assuming that the mass transfer coefficient remains 
constant while the surface area of the slug changes with time.  This yields Equation 13, 
which is a general form of the mass transfer equation that describes the amount of drug 
dissolved per unit volume at a given time t. 
                                            
( ) ( )














−−= ∫
t
L
s dttAV
kCtC
0
exp1
                         Equation 13 
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 Before determining a mathematical expression for A(t), the change in the overall 
surface area as a function of time for a disintegration process, the slug breakage 
mechanism needs to be defined.  Figure 9 presents a schematic diagram that shows a slug 
that is broken into a portion known as the unbroken slug as well as some disintegrated 
particles.  To simplify the formulation of the problem, the cylindrical slug was modeled 
as a sphere with its equivalent initial volume.  This allows for the surface area and the 
volume of the slug to be determined directly from the radius using the spherical model, 
resulting in a one-parameter model.  A cylindrical model requires both the dimensions of 
the radius and the length of the cylinder to determine the surface area and volume of the 
slug, rendering the model development and subsequent mathematical expressions 
significantly more complex.  This spherical slug was thus assumed to break into an 
unbroken portion and some disintegrated particles, where the involved particles were 
assumed to be spherical in shape.  These are collectively presented in Figure 9.  
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Figure 9.  Schematic diagram of the slug disintegration process ((a) initial breakage, 
cylindrical shape.  (b) transient breakage, cylindrical shape.  (c) spherical model 
breakage).   
 
In addition to adopting a spherical model for the dissolution model development, 
the following assumptions were also made: 
• The dissolution medium was well-mixed. 
• The initial concentration of dissolved drug in the medium was zero. 
• The mass transfer coefficient was independent of time, slug surface area, and 
disintegrated particles surface area. 
• The slug was composed of spherical particles with discrete sizes. 
As described in Figure 9, the slug disintegration process consists of two breakage 
processes: the breakage of the parent slug into a new, smaller unbroken slug; and the 
generation of disintegrated particles that may break apart further into smaller particles.  
The breakage of the parent slug into a new, smaller unbroken slug, which is the size 
reduction of the slug as a function of time, was assumed to follow an exponential decay 
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described by Equation 14.  Here, rSl,b+1 is the radius of the unbroken slug at time tb+1, ρSl 
is the density of the slug that was assumed to be constant, and rnSl,b is the radius of the 
slug after diffusion at time tb.  Additionally, γ is the disintegration constant or slug 
breakage coefficient defined in this study.  The magnitude of the slug breakage 
coefficient has a direct impact on the rate of the slug disintegration during the dissolution 
process.  Note that initially at time zero, tb+1 = t0 and rSl,b+1 = rnSl,b = rSl,0, which is the 
initial radius of the slug.  Accordingly, the surface area, ASl,b+1, and volume, VSl,b+1, of the 
unbroken slug can be found at each time interval, as described by Equations 15 and 16. 
                                                   
rSl,b +1 = rnSl,b exp −
γvθ
ρSl
tb +1
 
 
 
 
 
                               Equation 14 
                                                           
ASl,b+1 = 4πrSl,b +1
2
                                       Equation 15 
                                                            VSl,b +1 =
4
3
πrSl,b +1
3
                                     Equation 16 
Once the volume of the unbroken slug is determined, the total volume of the 
freshly disintegrated particles from the slug at time tb+1, Vp,b+1, can be obtained.  The 
volume of the leftover particles, VLp,b+1, which equals the volume of the undissolved 
particles, Vnp,b, that did not dissolve at time tb, can then be obtained.  These are described 
by Equations 17 and 18, respectively, where VnSl,b is the slug volume after dissolution at 
time tb.  At time tb+1 = t0, VnSl,b equals the initial slug volume, VSl,0.  Initially, Vnp,b equals 
zero as no disintegration has taken place.  However, at any time tb other than t0, the drug 
concentration, C(t), in the dissolution medium must be determined using Equation 13 
before the values for VnSl,b and Vnp,b can be calculated.  The surface area expression, A(t), 
needs to be established first. 
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                                                       Vp,b +1 = VnSl ,b −VSl ,b +1                                     Equation 17 
                                                             VLp,b +1 = Vnp,b                                           Equation 18 
Once the expression for the surface area is known, the drug concentration in the 
dissolution medium at each time, tb, can be determined.  Therefore, the volume of the 
sample dissolved, Vdif,b, at each time, tb, can be computed according to Equation 19.  
Subtracting the volume of the dissolved material from the initial slug volume, the volume 
of the undissolved material, Vnet,b, was obtained, as described by Equation 20.   The 
volume of the particles, Vnp,b, and the volume of the slug, VnSl,b, which remained 
undissolved at time tb, were estimated using Equations 21 and 22.  The slug radius, rnSl,b, 
after diffusion at time tb was calculated from Equation 23.  This radius value was 
substituted back into Equation 14, and the iterative process continued until the end of the 
dissolution test was reached.  In this study, the dissolution test was completed after 60 
minutes of simulation time. 
                                                           Vdif ,b =
C(tb )VL
ρSl
                                      Equation 19 
                                                         Vnet,b = VSl 0 −Vdif ,b                                     Equation 20 
                                               Vnp,b = Vnet,b
VLp ,b +Vp,b
VSl ,b +VLp,b +Vp,b
 
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  
 
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                            Equation 21 
                                                         VnSl,b = Vnet,b −Vnp ,b                                    Equation 22 
                                                           rnSl,b =
3VnSl ,b
4π
 
 
 
 
 
 
1
3
                                     Equation 23 
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To calculate the surface area of all the disintegrated particles, the size and number 
of the particles had to be determined.  If the size of each disintegrated particle is known, 
the surface area can be obtained from the surface area equation for a sphere.  
Furthermore, if the number of particles for each particle size is also known, then the total 
surface area of all the disintegrated particles can be determined.   
Since the slug was only lightly compressed, it could be assumed that the particle 
size distribution of the disintegrated particles would follow the particle size distribution 
of the original powder blend at time t0.  This was accomplished by adopting the ascorbic 
acid particle size distribution data measured by Heda et al. [45].  However, as the 
unbroken slug continues to disintegrate, the disintegrated particles from earlier time 
intervals may either dissolve via a diffusion process or break into smaller particles.  If the 
slug breaks into smaller particles, the particle size distribution of ascorbic acid at t0 is no 
longer pertinent and a new particle size distribution evolves.   
 To predict the new particle size distribution at each time interval, the Markov 
chain model was used to provide a discrete solution to the population balance equations 
of particle breakage [48].  There are many other methods available for conducting 
population balance modeling.  Many of these other methods employ continuous density 
functions [49-53].  Equation 24 shows a general continuous population balance equation 
used to model particle breakage processes.  Here, f(x,t) is the number density function for 
size x particles at time t and b(x,y) is the probability distribution for size x particles that 
are formed from the breakage of size y particles.  S(y) and S(x) are the respective 
breakage frequencies of size y and size x particles [48].  These functions can be used to 
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build powerful models.  However, the complexity of utilizing these functions makes it 
very difficult to obtain a closed form analytical solution.  The Markov chain approach, on 
the other hand, enables the solution of the population balance equations in a discrete 
manner.  This approach is described by Equation 25 [48].  Here, i is an arbitrary state 
number representing each discrete particle size with diameter xi, Ni(t) represents the 
number of particles in state i at time t, ∆Ni(t) is the rate of change of the number of 
particles, bji is the probability distribution for particles in state i that are formed from the 
breakage of particles in state j, τ is the time step, and Si is the breakage frequency of 
particles in state i.   
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The basic underlying principle of the Markov chain model is that the prediction of 
any future states depends only on the present state and not on any of the past states.  This 
means that as long as the current particle size distribution or the state probability, ai(tb), is 
known, the state probability, ai(tb+1), at a future time, tb+1, can be calculated. 
To predict the state probability, ai(tb+1), for particles in state i at time tb+1, the 
Markovian transition matrix, P, needs to be determined.  The transition matrix, P, as 
shown in Equation 26, is defined as the sum of a lower triangular matrix, L, and a 
diagonal matrix, D [48].  In comparing Equation 25 with Equation 26, L and D can be 
determined from Equations 27 and 28, where Li and Bi are row i of matrix L and matrix 
B, respectively, and Dii represents the diagonal value of the matrix D. 
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                                                               P = L + D                                             Equation 26 
                                                               Li = τSiBi                                            Equation 27 
                                                              Dii =1−τSi                                            Equation 28 
One of the requirements of the Markov chain approach is that two consecutive 
states should either have a constant interval or a constant ratio; the model may be 
expressed by uniform discretization or geometric discretization.  To discretize the 
population balance uniformly, the particle size distribution measured by Heda et al. [45] 
was used to estimate the cumulative percentage of seven uniformly spaced particle sizes.  
The resulting state probability, ai, for each of the seven state, i, with diameter, xi, at time 
tb = t0 was determined.  In addition, the lower limit, di-1, and upper limit, di, of state 
interval i were calculated from Equations 29 and 30.  A detailed description of the 
computational process of the cumulative particle size distribution and the resulting 
probability data can be found in Appendix B. 
                                                      
di−1 = x i −
x i+1 − x i
2
 
 
 
 
 
                                   Equation 29 
                                                       
di = x i +
x i+1 − x i
2
 
 
 
 
 
                                     Equation 30 
In this model, where i consists of seven states, the state probability vector, a(t), is 
made up of seven state probabilities, ai(tb), while the transition matrix, P, is a 7 x 7 matrix 
with pij corresponding to the probability of transition from state i to state j.  It was 
assumed that disintegrated particles exist in one of the seven discrete particle size states 
from state i = 1 to i = 7.  In addition, the disintegrated particles that did not dissolve into 
the dissolution medium via diffusion at earlier time intervals continue to break discretely 
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according to the particle size distribution, from state i = 7 (largest particle size) to state i 
= 1 (smallest particle size).  The model assumed that no further breakage occurs when a 
particle size of 74 µm is attained.  This implies particles with a diameter of 74 µm will 
only dissolve into the solution by diffusion.  Note that 74 µm was chosen as the particle 
size where no further breakage occurs because it was the smallest sieve fraction size used 
by Heda et al. [45].  Thus, no data is available for particles below this size range. 
To determine the transition matrix, P, the breakage frequency, Si, is defined.  In 
this model, the particles were assumed to break according to the breakage frequency, Si, 
described by Equation 31 for all states, i, between 2 and 7, where α is the particle 
breakage coefficient.  At state i = 1, which is the state with the smallest particle size, Si is 
equal to zero.  This is because it was assumed that no further breakage occurs when 74 
µm (state i = 1) is reached.  The diagonal matrix, D, was estimated by computing Dii 
using Equation 28, where τ was selected to be 30 seconds under the constraint that τSi 
will not be larger than 1. 
                                                                 Si = αx i
3
                                             Equation 31 
 Next, the lower triangular matrix, L, was found using Equation 27.  Here, Bi is the 
row i of matrix B with component bji.  Assuming the probability for a parent particle to 
break into smaller particles with any size was the same, b(x,y) can be described by 
Equation 32 [48].  The equation describing b(x,y) can be integrated to give bji in a 
discrete form.  Equation 33 was used to determine bji when 2 ≤ j ≤ 7 and 1 ≤ i ≤ j.  
Otherwise, bji is equal to zero.  This is because only larger particles (state j) can break 
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into smaller fragments (state i).  With bji being defined, the lower triangular matrix, L, 
can be determined.  Equation 34 presents L for a n x n matrix.   
                                                            
b x,y( )= 6x
2
y 3
                                         Equation 32 
                                                       
b ji =
2
d j −1
3 di
3 − di−1
3( )                                    Equation 33 
                                    L =
0 0 ⋅ ⋅ ⋅ 0 0
τS2b21 0 ⋅ ⋅ ⋅ 0 0
τS3b31 τS3b32 ⋅ ⋅ ⋅ 0 0
⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅
⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅
⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅
τSnbn1 τSnbn 2 ⋅ ⋅ ⋅ τSnbn ,n −1 0 n ×n
                 Equation 34 
By summing matrices D and L, the transition matrix, P, was obtained.  The state 
probability vector, a(t), for any future time step can therefore be evaluated from Equation 
35. 
                                                           
a t +τ( ) = a t( )P                                         Equation 35 
Knowing the probability, ai(tb), of having particle size of state xi at time tb, the 
total volume, Vi(tb), of the disintegrated particles at each particle size of state xi can be 
determined from Equation 36.  Since the disintegrated particles were assumed to exist in 
discrete states of known sizes with each state, xi, as defined in Appendix B, the surface 
area, Asi, and volume, Vsi, of the individual disintegrated particle at each state can be 
found.  These are described by Equations 37 and 38, respectively.  Consequently, the 
number of particles, ni(tb), in each state, xi, at time tb can be determined from Equation 
39, and the surface area, ATpi(tb), of all the disintegrated particles at each state, xi, can be 
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found from Equation 40.  Finally, the overall surface area, A(tb), from all the 
disintegrated particles, as well as the unbroken slug, that are available for the diffusion 
process at time tb can be obtained from Equation 41. 
                                                
Vi tb( )= VLp,bai tb( )+Vp,bai t0( )                             Equation 36 
                                                              Asi = 4πx i
2
                                            Equation 37 
                                                              Vsi =
4
3
πx i
3
                                           Equation 38 
                                                           
ni tb( )=
Vi tb( )
Vsi
                                        Equation 39 
                                                        
ATpi tb( )= ni tb( )Asi                                      Equation 40 
                                                   
A tb( )= ATpi tb( )
i=1
7
∑ + ASl,b                                 Equation 41 
Substituting Equation 41 into Equation 13, an analytical expression that describes 
slug dissolution process, with the disintegration process being captured through the 
surface area equation, was established.  Equation 42 presents this overall expression. 
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             Equation 42 
 Equation 42 can be conveniently converted into an expression that describes the 
slug dissolution process via erosion only.  This is achieved by setting the breakage 
coefficient, γ, to zero.  Similarly, this equation can be used to describe a pure 
disintegration process without any diffusion by simply setting the mass transfer 
coefficient, k, to zero. 
 
49 
4.1.2 Capsule Shell and Overall Dissolution Model Development 
The dissolution of a capsule shell was assumed to follow an erosion mechanism 
and diffuse into the dissolution medium.  In the literature, the reported time for this 
process may be as long as 300 seconds [39].  This is a relatively short amount of time in 
comparison to the overall capsule dissolution process.  Due to this short amount of time, 
it was assumed that A(t) will be similar to the initial surface area, AG, of the capsule 
shell.  In addition, the mathematical model assumed that capsule shell dissolution and 
slug dissolution occur in a sequential fashion.  Applying the same general form of the 
mass transfer equation that describes the amount of drug dissolved per unit volume at a 
certain time t to the gelatin shell dissolution, Equation 43 was obtained.  Here, kG is the 
mass transfer coefficient for the gelatin shell, Gs is the saturated solubility of gelatin, and 
G is the solubility of the gelatin shell at time t.  Integration of Equation 43 results in the 
expression for capsule shell dissolution via an erosion process, resulting in the expression 
described by Equation 44. 
                                                      
dG
dt
=
kG AG
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Gs − G( )                                    Equation 43 
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The overall capsule dissolution model is comprised of both the capsule shell and 
capsule slug dissolution processes.  This is expressed as Equation 45, where CT (t) is the 
overall shell plus slug concentration at time t.  The first term on the right of Equation 45 
describes the gelatin shell dissolution process from time zero to time tG.  The second term 
describes the slug dissolution process from time tG to the end of the dissolution test of 
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time t.  The slug dissolution process usually takes about 60 minutes or more.  Therefore, 
the time, tG, needed for shell dissolution, which is typically less than five minutes (300 
seconds), can be neglected.  Consequently, Equation 42 alone is sufficient to describe the 
capsule dissolution process.  In summary, a mathematical model comprising both the 
erosion process of the capsule shell and the two mass transfer processes that a slug 
undergoes, the disintegration process and the erosion process, was developed. 
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dt
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4.2 Mass Transfer Coefficient Estimation 
 
To complete the mathematical model, the mass transfer coefficient for the slug 
was determined.  The methods of estimation are described below. 
The mass transfer coefficient of the slug was determined from experimental data 
as well as from theoretical calculations, in a similar manner as conducted by Bai et al. 
[17].  The integrated form of the mass transfer equation, as described by Equation 46, 
together with experimental dissolution data from the literature, were used to obtain the 
experimentally determined mass transfer coefficient of the slug, kexp.  Equation 46 
assumed that the mass transfer coefficient is independent of time [17].  Here, kexp is the 
mass transfer coefficient, VL is the dissolution medium volume, Ct is the drug 
concentration in the medium at time t (which can be obtained from the experimental 
dissolution data), C0 is the initial drug concentration in the medium, Cs is the saturated 
solubility of the drug, C is the drug concentration in the medium, dSl0 is the initial slug 
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diameter, ρSl is the density of the slug, and β is the height-to-diameter ratio of the slug.  
The derivation of Equation 46 can be found in Appendix C.   
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To calculate the mass transfer coefficient, ktheo, of the slug theoretically, the mass 
transfer coefficient equation for a rotating cylinder as shown in Equation 8, together with 
the CFD-predicted tangential velocities data as presented in Tables 1 and 2 in Section 2.2, 
were used.  Although the slug is also cylindrical in shape, it is positioned down on its 
surface side instead of the ends.  Additionally, the surface area around the surface is 
much larger than that of the two ends.  Therefore, it is reasonable to use only the mass 
transfer coefficient equation for a rotating cylinder to estimate the slug mass transfer 
coefficient.  In Equation 8, dT is the diameter of the tablet.  This diameter was estimated 
by taking the average of the sum of the initial diameter, dSl0, and initial length, LSl0, of the 
slug.  The rotating Reynolds number, RΩ, and the Schmidt number, Sc, are defined 
according to Equations 47 and 48 [17].  The velocity term, uΩ, in Equation 47 is the 
velocity at the periphery of the cylinder, which was assumed to be the tangential velocity, 
vθ, of the fluid adjacent to the slug. 
                                                                 
ReΩ =
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2
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                                            Equation 47 
                                                              
Sc = µ
DABρ
                                            Equation 48 
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If the same size of tablet and capsule are in the same position in the dissolution 
vessel, the velocities around them should be similar.  Additionally, the CFD-predicted 
velocity vectors around the tablet surface location as shown in Table 3 are similar with or 
without a tablet in the vessel.  It is reasonable to assume that hydrodynamic effects on a 
tablet would be similar on a capsule.  Therefore, the CFD-predicted tangential velocities 
from the referenced literature were used to calculate the capsule slug mass transfer 
coefficient.  The mass transfer coefficient values calculated experimentally and 
theoretically were compared and incorporated into the mathematical expression for the 
capsule dissolution to complete the model.  
4.3 Numerical Simulation and Statistical Analysis 
The mass transfer process of capsule dissolution, under the effect of the 
hydrodynamic conditions of the USP Apparatus II, was mathematically modeled by 
coupling the mass transfer coefficients.  The effects of tangential velocity and slug size 
on the capsule dissolution profiles, as well as three extreme dissolution cases, were 
evaluated.  The model was validated by statistically comparing the generated dissolution 
profiles against the published dissolution data.  The degree of agreement between the 
model and published data was evaluated by the similarity factor.   
 The similarity factor is one of the methods recommended by the FDA for 
comparing similarities or differences between dissolution profiles [1].  This model-
independent approach utilizes a pair-wise procedure to compare dissolution profiles 
based on the values of a difference factor, f1, which ranges from 0 to 100, and a similarity 
factor, f2, which ranges from -∞ to 100 [17, 54].  If two profiles are extremely different, 
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the f2 value will approach -∞.  If they are deemed to be identical, then f2 is 100.  The 
difference factor and the similarity factor represent the absolute differences and the 
squared differences in population averages between cumulative dissolution values of the 
reference and test assays at all time points, respectively, where only one sample point is 
allowed to contain more than 85% dissolution of the drug product [55, 56].  While the 
difference factor measures the percent error between two dissolution profiles, the 
similarity factor compares the mean differences in dissolution values between the 
reference and test samples without accounting for differences within each sample type.  
The difference factor and similarity factor were determined according to Equations 49 
and 50, respectively, where n is the number of time points, Rt is the dissolution value of 
the reference assay at time t, and Tt is the dissolution value of the test assay at the same 
time, t [1, 17].   
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According to the FDA, two dissolution profiles are similar if f1 lies between 0 and 
15 and f2 lies between 50 and 100 [1].  An f2 value of 50 corresponds to an average 
difference of 10% between two dissolution profiles at any time point, and this value 
increases as the average difference is reduced.  If the f1 and f2 values of the simulated and 
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the published dissolution profiles meet these criteria, the mathematical model developed 
in this study, which combines the mass transfer principles as well as the hydrodynamic 
effects within the USP Apparatus II, would be considered a valid model to describe 
capsule dissolution testing. 
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CHAPTER FIVE                                                                                        
RESULTS 
 
 
A capsule dissolution model has been developed for a slug inside a gelatin 
capsule shell in a USP Apparatus II.  This chapter presents the results of the model 
simulations.  These include the mathematical expressions for capsule shell and slug 
dissolutions, the estimation of the mass transfer coefficient, and the simulated capsule 
dissolution profiles. 
5.1 Mathematical Model 
The mathematical model was developed under the assumption that the capsule 
shell dissolution and the slug dissolution occur in a sequential fashion.  This assumes that 
ascorbic acid does not diffuse into the dissolution medium until the gelatin capsule shell 
has completely dissolved.  Equation 44 from Section 4.1.2 describes the capsule shell 
dissolution process.  This equation, however, was not incorporated into the dissolution 
simulation process since the shell dissolution process is relatively short (within five 
minutes) compared to the one-hour slug dissolution process.  In addition, only the drug 
concentration is typically being monitored over time when conducting the dissolution 
experiments.  The change in concentration of the capsule shell in the dissolution medium 
is usually neglected. 
The slug dissolution model was developed through a combination of the general 
form of the mass transfer equation, the theoretical mass transfer coefficient with the use 
of CFD-predicted tangential velocity, the initial particle size distribution of ascorbic acid 
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from Heda et al. [45], and the probability of generating particles of discrete sizes through 
the application of the Markov chain.  The model development process was discussed in 
Section 4.1.1.  All the computed values for the matrices, D, L, and P, of the Markov 
chain, which are essential for the state probability vector estimation, can be found in 
Appendix D.  These values were calculated with the particle breakage coefficient, α, 
equal to 10-10 µm-3s-1 and the time step, τ, equal to 30 seconds.  A graph showing the state 
probability vector, a(t), for particle size distribution from zero to 60 minutes is also 
presented in Appendix D.  The state probability vector is required in the model 
simulation to account for particle breakage during dissolution.  The result is a 
mathematical expression that describes the slug dissolution process via pure 
disintegration, pure erosion, or a combination of both as presented by Equation 42.       
5.2 Mass Transfer Coefficients 
A mass transfer coefficient was determined experimentally and theoretically.  
Experimental data obtained from Heda et al. [45], as well as the ascorbic acid slug and 
the dissolution system properties, are reported in Tables 5 and 6, respectively.  The 
dissolution data were plotted and the profile was fitted with a fourth order polynomial 
equation as shown in Figure 10.  The polynomial equation was used to estimate discrete 
concentration values as a function of time at one-minute intervals up to 40 minutes.  The 
concentration obtained from this polynomial equation started to diverge from the 
experimental data beyond 40 minutes.  The values obtained, together with the properties 
of ascorbic acid and the dissolution system, were incorporated into Equation 46.  The 
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experimental mass transfer coefficient, obtained by numerical integration of Equation 46 
from time zero to 40 minutes, was 106.61 mm/min. 
Table 5.  Dissolution data of the ascorbic acid slug in size 1 capsules. 
T (minutes) C (%) 
3 14 
5 27 
7 38 
10 46 
15 59 
30 84 
45 95 
60 100 
 
Table 6.  Properties of the ascorbic acid slug and dissolution system used in kexp 
estimation. 
 
Properties Values 
VL (mL) 1000 
LSl0 (mm) 16.46 
dSl0 (mm) 6.3 
β 2.61 
VSl0 (mm3) 513.10 
ρSl (mg/mm3) 0.49 
Cs (mg/mL) 0.25 
C0 (mg/mL) 0 
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Figure 10.  Dissolution graph and polynomial fit of ascorbic acid. 
 To estimate the theoretical mass transfer coefficient, the tangential velocity of the 
system was first determined from the CFD-predicted data presented in Tables 1, 2, and 3.  
With the slug resting on its side during dissolution testing, the height of the slug from the 
bottom of the vessel was approximately 6.3 mm.  Figure 11 figuratively presents the 
capsule location inside a dissolution vessel.  Assuming the slug was located at the center 
of the vessel and the rotational axis was at the center of the slug, the longer side of the 
slug would be located at about 8.23 mm from the center of the shaft, which is half of the 
length of the slug.  The shorter side of the slug, on the other hand, would be located at 
about 3.15 mm from the shaft center.  This is approximately half the diameter of the slug.  
Putting these dimensions together and comparing to Tables 1, 2, and 3, the tangential 
velocity should be roughly between 0.029 m/s to 0.058 m/s.  The mass transfer 
coefficient was estimated by selecting three tangential velocities from this range: the 
lower limit, the upper limit, and the average value.  Equations 8, 10, 47, and 48 were used 
to estimate the theoretical mass transfer coefficient, where ktheo is equal to kside in 
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Equation 8.  The values of the variables, such as the properties of the dissolution medium 
and ascorbic acid that were used in determining the mass transfer coefficient with the 
average tangential velocity, are reported in Appendix E.  Although the actual dissolution 
medium used in the study was 0.1N HCl, properties of water were used in these 
equations.  The tangential velocities and the corresponding theoretical mass transfer 
coefficients are presented in Table 7.  The theoretical mass transfer coefficient estimated 
from this method was found to range from 0.29 mm/min to 0.47 mm/min, depending on 
the magnitude of the tangential velocity. 
 
Figure 11.  Location of capsule inside dissolution vessel (top view). 
 
Table 7.  Tangential velocities and theoretical mass transfer coefficients. 
 
vθ (m/s) vθ (mm/min) ktheo (mm/min) Notes 
0.029 1740 0.29 Lower limit 
0.044 2640 0.39 Mid-point 
average 
0.058 3480 0.47 Upper limit 
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5.3 Simulated Dissolution Profiles and Statistical Comparison 
 
The estimated mass transfer coefficients and the mathematical model were 
coupled together to simulate dissolution profiles.  The effects of tangential velocity, as 
well as the size of the slug on the dissolution profile, were also evaluated.  In addition, 
three extreme dissolution cases were simulated.  Values for the slug breakage coefficient 
and the particle breakage coefficient were selected such that the simulated profiles could 
be best fitted with experimental data.  Table 8 reports the variables that have constant 
values for all the model simulations in this study. 
Table 8.  Variables with constant values in the capsule dissolution model simulation. 
Variables Value Notes 
VL (mL) 1000 Dissolution medium 
Cs (mg/mL) 0.25 Saturated drug solubility 
τ (s) 30 Breakage time step 
 
5.3.1 Dissolution Profile with Experimental Mass Transfer Coefficient 
 
 First, a dissolution profile was simulated by incorporating the experimental mass 
transfer coefficient into the model.  Table 9 presents the values of the variables used to 
simulate this dissolution profile.  Figure 12 presents the resulting profile with the use of 
the experimental mass transfer coefficient.  The experimental dissolution profile from 
Heda et al. [45] is also included in these figures for comparison purposes.  It is very clear 
that the experimental mass transfer coefficient was over-estimated, resulting in an 
immediate dissolution profile.   
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Table 9.  Variables used in the capsule dissolution model simulation with kexp. 
Variables Value Notes 
LSl0 (mm) 16.46 Slug length 
dSl0 (mm) 6.3 Slug diameter 
VSl0 (mm3) 513.10 Slug volume 
rSl0 (mm) 4.97 Slug volume equivalent sphere radius 
ρSl (mg/mm3) 0.49 Slug density 
vθ (mm/min) 2640 Tangential velocity 
kexp (mm/min) 106.61 Mass transfer coefficient (experimental) 
γ (mg/mm4) 2*10-10 Slug breakage coefficient 
α (µm-3 s-1) 10-10 Particle breakage coefficient 
 
 
Figure 12.  Simulated dissolution profile with experimental mass transfer coefficient (kexp 
= 106.61 mm/min; γ = 2*10-10 mg/mm4; α = 10-10 µm-3 s-1) and experimental dissolution 
data. 
 
5.3.2 Dissolution Profiles with Different Tangential Velocities—Theoretical Mass 
Transfer Coefficients 
 
  The three tangential velocities and their corresponding theoretically estimated 
mass transfer coefficients, presented in Table 7, were incorporated into the capsule 
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dissolution model.  The variables used to simulate these profiles are reported in Table 10.  
The resulting simulated profiles are presented in Figures 13 to 15.  Unlike the profile 
generated using the experimental mass transfer coefficient, the three dissolution profiles 
simulated using theoretical mass transfer coefficients gave profiles fairly similar to the 
experimental data. 
Table 10.  Variables used in the capsule dissolution model simulation—ktheo. 
Variables Lower limit Mid-point Upper limit Notes 
LSl0 (mm) 16.46 Slug length 
dSl0 (mm) 6.3 Slug diameter 
VSl0 (mm3) 513.10 Slug volume 
rSl0 (mm) 4.97 Slug volume equivalent sphere radius 
ρSl 
(mg/mm3) 0.49 Slug density 
vθ 
(mm/min) 1740 2640 3480 Tangential velocity 
ktheo 
(mm/min) 0.29 0.39 0.47 
Mass transfer coefficient 
(theoretical) 
γ (mg/mm4) 2*10-10 Slug breakage 
coefficient 
α (µm-3 s-1) 10-10 Particle breakage 
coefficient 
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Figure 13.  Dissolution profile with the lower limit of tangential velocity (vθ = 1740 
mm/min; ktheo = 0.29 mm/min; γ = 2*10-10 mg/mm4; α = 10-10 µm-3 s-1) and experimental 
dissolution data. 
 
 
Figure 14.  Simulated dissolution profile with average tangential velocity (vθ = 2640 
mm/min; ktheo = 0.39 mm/min; γ = 2*10-10 mg/mm4; α = 10-10 µm-3 s-1) and experimental 
dissolution data. 
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Figure 15.  Dissolution profile with the upper limit of tangential velocity (vθ = 3480 
mm/min; ktheo = 0.47 mm/min; γ = 2*10-10 mg/mm4; α = 10-10 µm-3 s-1) and experimental 
dissolution data. 
 
Furthermore, the capsule in this study was assumed to be centrally located in the 
vessel.  To check the validity of this assumption, a tangential velocity that corresponds to 
an off-centered location in the vessel was incorporated into the model.  The location 
selected was at a radius of approximately 35 mm from the center of the shaft and 19.05 
mm from the vessel bottom, as shown in Figure 16.  This gives a tangential velocity of 
4680 mm/min and a mass transfer coefficient of 0.57 mm/min.  The variables 
incorporated into the model to simulate the dissolution profile for an off-centered capsule 
are reported in Table 11.  The resulting profile is presented in Figure 17.   
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Figure 16.  Centrally located and off-centered capsules inside a dissolution vessel. 
 
Table 11.  Variables used in the capsule dissolution model simulation—off-centered 
capsule. 
 
Variables Value Notes 
LSl0 (mm) 16.46 Slug length 
dSl0 (mm) 6.3 Slug diameter 
VSl0 (mm3) 513.10 Slug volume 
rSl0 (mm) 4.97 Slug volume equivalent sphere radius 
ρSl (mg/mm3) 0.49 Slug density 
vθ (mm/min) 4680 Tangential velocity 
k (mm/min) 0.57 Mass transfer coefficient 
γ (mg/mm4) 2*10-10 Slug breakage coefficient 
α (µm-3 s-1) 10-10 Particle breakage coefficient 
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Figure 17.  Dissolution profile with tangential velocity corresponds to an off-centered 
capsule (vθ = 4680 mm/min; k = 0.57 mm/min; γ = 2*10-10 mg/mm4; α = 10-10 µm-3 s-1) 
and experimental dissolution data. 
 
5.3.3 Dissolution Profile with Smaller Slug Dimension 
 
The effect of slug dimension was also investigated.  Instead of assuming that the 
capsule body was fully filled with the slug materials, it was assumed that the capsule was 
only 75% filled.  This corresponds to a slug length of 12.35 mm.  The overall volume of 
the slug was therefore reduced by 25%.  Since the amount of slug materials remained the 
same, the density of the slug increased from 0.49 mg/mm3 to 0.65 mg/mm3.  The 
variables used to simulate the dissolution profile for a capsule with this reduced filled 
volume are reported in Table 12.  The average tangential velocity of 2640 mm/min was 
used for this simulation.  The resulting simulated profile is presented in Figure 18. 
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Table 12.  Variables used in the capsule dissolution model simulation—smaller slug 
dimension. 
 
Variables Value Notes 
LSl0 (mm) 12.35 Slug length 
dSl0 (mm) 6.3 Slug diameter 
VSl0 (mm3) 384.82 Slug volume 
rSl0 (mm) 4.51 Slug volume equivalent sphere radius 
ρSl (mg/mm3) 0.65 Slug density 
vθ (mm/min) 2640 Tangential velocity 
k (mm/min) 0.39 Mass transfer coefficient 
γ (mg/mm4) 2*10-10 Slug breakage coefficient 
α (µm-3 s-1) 10-10 Particle breakage coefficient 
 
 
Figure 18.  Dissolution profile with a 75% filled capsule (k = 0.39 mm/min; γ = 2*10-10 
mg/mm4; α = 10-10 µm-3 s-1) and experimental dissolution data. 
 
5.3.4 Dissolution Profiles for Extreme Cases 
 
To further validate the model, three extreme cases were evaluated.  These are the 
pure erosion process, fast disintegration process, and pure disintegration process without 
diffusion.  For the pure erosion process, the slug breakage coefficient was set as zero.  
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For the fast disintegration process, the slug breakage coefficient was adjusted such that 
there was no more unbroken slug one minute after dissolution.  VSl at t equal to one 
minute should be zero.  For the pure disintegration without diffusion process, the mass 
transfer coefficient was set as zero, and any slug breakage coefficient produced a 
dissolution profile with the same shape.  This is because nothing dissolved and the 
particles were suspended in the dissolution medium.  The variables used to simulate 
dissolution profiles for these three cases are reported in Table 13.  Their dissolution 
profiles are presented in Figures 19 to 21. 
Table 13.  Variables used in the capsule dissolution model simulation—extreme cases. 
Variables Pure Erosion 
Fast 
Disintegration 
Pure 
Disintegration Notes 
LSl0 (mm) 16.46 Slug length 
dSl0 (mm) 6.3 Slug diameter 
VSl0 (mm3) 513.10 Slug volume 
rSl0 (mm) 4.97 Slug volume equivalent sphere radius 
ρSl (mg/mm3) 0.49 Slug density 
vθ (mm/min) 2640 Tangential velocity 
k (mm/min) 0.39 0 Mass transfer coefficient  
γ (mg/mm4) 0 0.1 2*10-10 Slug breakage coefficient 
α (µm-3 s-1) 0 10-10 10-10 Particle breakage 
coefficient 
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Figure 19.  Dissolution profile for pure erosion process (k = 0.39 mm/min; γ = 0 
mg/mm4; α = 0 µm-3 s-1) and experimental dissolution data. 
 
 
Figure 20.  Dissolution profile for fast disintegration process (k = 0.39 mm/min; γ = 0.1 
mg/mm4; α = 10-10 µm-3 s-1) and experimental dissolution data. 
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Figure 21.  Dissolution profile for pure disintegration process without diffusion (k = 0 
mm/min; γ = 2*10-10 mg/mm4; α = 10-10 µm-3 s-1) and experimental dissolution data. 
 
5.3.5 Dissolution Profile with Adjusted Coefficients 
 
 The mass transfer coefficient, slug breakage coefficient, and particle breakage 
coefficient could all be adjusted to bring the simulated dissolution profile closer to the 
experimental profile.  It is expected that a larger mass transfer coefficient would result in 
a faster dissolution profile, as materials transfer faster from the slug to the dissolution 
medium.  Similarly, a larger slug breakage coefficient and a larger particle breakage 
coefficient both imply faster material breakage, both of which increase the surface area 
available for diffusion to take place.  According to Equation 3, the rate of drug 
dissolution is directly proportional to the slug surface area.  Therefore, an increase in 
surface area because of faster material breakage should also result in a faster dissolution 
profile.  By selecting the mass transfer coefficient as 0.23 mm/min, the slug breakage 
coefficient as 2*10-9 mg/mm4, and the particle breakage coefficient as 10-10 µm-3 s-1, the 
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simulated and experimental dissolution profiles almost perfectly overlapped with each 
other.  The variables used to simulate this dissolution profile are reported in Table 14.  
The dissolution profile is presented in Figure 22. 
Table 14.  Variables used in the capsule dissolution model simulation—adjusted 
coefficients. 
 
Variables Value Notes 
LSl0 (mm) 16.46 Slug length 
dSl0 (mm) 6.3 Slug diameter 
VSl0 (mm3) 513.10 Slug volume 
rSl0 (mm) 4.97 Slug volume equivalent sphere radius 
ρSl (mg/mm3) 0.49 Slug density 
vθ (mm/min) 1200 Tangential velocity 
k (mm/min) 0.23 Mass transfer coefficient 
γ (mg/mm4) 2*10-9 Slug breakage coefficient 
α (µm-3 s-1) 10-10 Particle breakage coefficient 
 
 
 
Figure 22.  Dissolution profile with coefficients adjusted to match experimental 
dissolution data (k = 0.23 mm/min; γ = 2*10-9 mg/mm4; α = 10-10 µm-3 s-1). 
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5.3.6 Statistical Comparison 
 
It is clear that the model with the experimental mass transfer coefficient did not 
effectively predict the ascorbic acid capsule dissolution profile.  However, the simulated 
dissolution profiles with the theoretically estimated mass transfer coefficients (Figures 13 
to 15) are similar to the experimental data.  These profiles were statistically compared to 
the experimental data using the difference factor and similarity factor.  The simulated 
profiles with the off-centered location and the smaller slug dimension, as well as the 
simulated profile with coefficients adjusted to match the experimental dissolution data, 
were also statistically compared to the experimental data. 
 Table 15 lists the dissolution values of the experimental data, Rt, and the 
simulated profiles, Tt, at time t.  These include the dissolution values of the capsules with 
various tangential velocities, off-centered location, 75% filled volume, and the near-
perfect profile with adjusted values.  The difference factor, f1, and the similarity factor, f2, 
were reported.  For two dissolution profiles to be considered similar, f1 should be 
between 0 and 15 while f2 should be between 50 and 100 [1].  Therefore, the simulated 
dissolution profile with the lower limit of tangential velocity, and that with the smaller 
slug dimension (75% filled), are considered to be similar to the experimental data.  The 
difference factor and the similarity factor for the simulated profile, where the coefficients 
were adjusted to closely match the experimental profile, are 3 and 81, respectively.  
According to the statistical analysis, the theoretical mass transfer coefficient that best 
described the experimental dissolution data is 0.29 mm/min. 
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Table 15.  Dissolution values of experimental data and various simulated profiles. 
 
Experimental 
data 
Lower 
limit 
vθ 
Average 
vθ 
Upper 
limit 
vθ 
Off-
centered 
75% 
filled 
Adjusted 
values 
vθ 
(mm/min) n/a 1740 2640 3480 4680 2640 1200 
t 
(minutes) Rt (%) Tt (%) 
3 14 22 29 33 38 24 19 
5 27 33 41 46 52 36 28 
7 38 42 50 55 61 44 36 
10 46 51 60 65 70 54 46 
15 59 63 71 75 80 66 59 
20 68 71 78 82 85 73 69 
30 84 81 86 89 92 83 83 
f1 n/a 10 24 32 42 14 3 
f2 n/a 65 46 39 34 57 81 
Similarity n/a yes no no no yes yes 
 
 In summary, mathematical expressions for capsule shell and capsule slug 
dissolution were developed, the mass transfer coefficient for the dissolution system was 
determined, and capsule dissolution profiles were simulated.  Figure 23 summarizes the 
key results obtained for each part of the model development process.   
    
Figure 23.  Summary of the key results for capsule dissolution model development. 
Mathematical model development 
1. Shell erosion (Equation 44) 
2. Slug erosion and 
disintegration (Equation 42) 
Mass transfer coefficient estimation 
1.   Experimental 
kexp = 106.61 mm/min 
2. Theoretical 
ktheo = 0.29 mm/min 
Numerical simulation 
Capsule dissolution profile (Figure 13) 
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CHAPTER SIX                                                                                               
DISCUSSION 
 
 
Mathematical models that describe capsule shell and slug dissolution processes 
have been generated.  In particular, the mathematical model portrays both disintegration 
and erosion processes for slug dissolution.  To validate the model, the mass transfer 
coefficients were estimated and coupled with the model to simulate several specific cases 
of the dissolution process.  In addition, the simulated profiles were statistically compared 
with the experimental dissolution data for similarity. 
The mass transfer coefficient incorporated in the model was estimated 
experimentally using experimental dissolution data and theoretically using CFD-
predicted tangential velocities.  Bai et al. [17] found that experimental and theoretical 
mass transfer coefficients for tablets were on the same order of magnitude where 
proportionality existed between the two.  However, the values obtained from the two 
methods in this work appeared to be substantially different from each other when 
capsules were considered.  The mass transfer coefficient estimated from experimental 
dissolution data suggests a rapid mass transfer process, and, subsequently, a fast 
dissolution profile.  Dissolution profiles generated from the model in which the 
experimental and theoretical mass transfer coefficients were incorporated further revealed 
the discrepancy of the experimentally estimated value.  As shown in Figure 12, the 
simulated profile using the experimental mass transfer coefficient resulted in an 
immediate release dissolution profile and did not match the experimental data generated 
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by Heda et al. [45].  The simulated dissolution profile using the theoretical mass transfer 
coefficient (0.29 mm/min), however, was statistically similar to the experimental profile 
generated by Heda et al. [45].  This could be because the equation used to estimate the 
mass transfer coefficient from the experimental data assumed a non-disintegrating slug 
throughout the entire dissolution testing.  The tablet that Bai et al. [17] studied was a non-
disintegrating tablet.  Therefore, it is reasonable that their experimental and theoretical 
mass transfer coefficients agreed with each other. 
The tangential velocities obtained from the CFD data to estimate theoretical mass 
transfer coefficients were chosen under the assumption that the slug was centrally located 
at the bottom of the vessel during dissolution testing.  Three dissolution profiles were 
simulated using three theoretically estimated mass transfer coefficients.  According to the 
difference and similarity factors, the simulated profile with a theoretical mass transfer 
coefficient of 0.29 mm/min showed good agreement with the experimental ascorbic acid 
dissolution curve.  This dissolution profile is obtained from the use of the lower limit of 
tangential velocity with the selected slug breakage coefficient and particle breakage 
coefficient.  The magnitude of the three coefficients together with the good agreement 
between the two profiles suggest that the ascorbic acid capsule dissolution was dominated 
by an erosion process with some slug and particle breakages.  The other two profiles, 
simulated using the average and the upper limit of tangential velocities, are not 
statistically similar to the experimental profile generated by Heda et al. [45].  Their 
difference factors are bigger than 15 and their similarity factors are smaller than 50.  The 
differences in these simulated profiles show that the dissolution profile is very sensitive 
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to the tangential velocity experienced by the capsule.  A capsule can experience different 
tangential velocity because of a slight change in location.  This difference in tangential 
velocity leads directly to a change in the mass transfer coefficient and therefore a change 
in the dissolution profile.  This is consistent with the observations reported in the 
literature for tablet dissolutions [9, 10, 15-17, 24, 25, 27].   
The effect of tangential velocity on capsule dissolution was also studied using an 
off-centered capsule.  This off-centered position resulted in a higher tangential velocity 
and therefore a higher theoretical mass transfer coefficient.  The resulting simulated 
profile showed a much faster capsule dissolution rate than the dissolution rates of the 
centrally located capsule and the capsules studied by Heda et al. [45].  Again, this agrees 
with the results reported in the literature, where a drug product at different locations 
inside the dissolution vessel experiences different hydrodynamics and therefore 
dissolution variations [9, 10, 15-19, 21, 24, 25, 27]. 
There are several factors that could have contributed to the variation observed in 
the simulated profile using the average tangential velocity in Figure 14.  First, the slug 
was assumed to be the size of a fully filled size 1 capsule.  This dimension was not 
provided by Heda et al. [45].  The dimensions of the slug can be important as they 
determine the density of the slug.  An increase in density reduces the dissolution rate.  To 
verify this effect and the importance of the slug dimensions, a simulation was conducted 
where the capsule was assumed to be 75% filled.  This led to a reduction in the length 
and the volume of the slug.  The resulting simulated profile showed that this reduction in 
filled volume slowed the dissolution rate.  Statistical comparison between the simulated 
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profile and the experimental profile generated by Heda et al. [45] shows that they are 
similar. 
In addition to the slug dimensions, the cylindrical slug was modeled as a sphere in 
the dissolution model development.  This could have imposed some differences in the 
surface area that is available for mass transfer to take place.  Furthermore, the mass 
transfer coefficient was assumed to be independent of time, slug surface area, and particle 
surface area in this study.  According to Equations 3 and 13, surface area changes with 
time, and a reduction in surface area may change the mass transfer coefficient.  Finally, 
the rate of slug and particles breakage would also potentially change the surface area and 
hence the dissolution profile.  
While the simulated profile with the use of a theoretical mass transfer coefficient 
of 0.29 mm/min validates the capsule dissolution model, three special cases that were 
considered to be extreme scenarios were evaluated to confirm the validity of the model.  
These three cases were the pure erosion process, the fast disintegration process, and the 
pure disintegration process without diffusion.  These cases were selected with the 
reasoning that if their simulated profiles correctly described the dissolution process, then 
any dissolution process that is a combination of them could be properly simulated.  The 
simulated profiles of these special cases were found to correctly predict the dissolution 
trend.  The dissolution profile of a pure erosion process should be slower than that of a 
fast disintegration process.  A reduction of mass transfer coefficient to the extreme case 
of zero collapsed the dissolution profile.  Last but not least, an increase in the slug 
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breakage coefficient, which intuitively increased the surface area, increased the 
dissolution rate. 
The mass transfer coefficient, slug breakage coefficient, and particle breakage 
coefficient collectively shape the dissolution profile.  An increase in the magnitude of any 
one of them with the rest being held constant, or an increase in the magnitude of all of 
them, would increase the dissolution rate.  Therefore, these three coefficients were 
adjusted to determine whether a simulated profile that perfectly matched the experimental 
data could be created.  By reducing the value of the mass transfer coefficient and 
increasing the value of the slug breakage coefficient of the dissolution profile in Figure 
13, the simulated profile almost overlapped with the experimental profile.  These changes 
in coefficients correspond to a slower diffusion process yet a slightly faster slug breakage 
process. 
In summary, the mathematical model developed in this study can be regarded as a 
valid model to describe capsule dissolution testing.  It clearly reflects the effect of 
hydrodynamics on dissolution profile, as reported in the literature [9, 10, 15-19, 21, 24, 
25, 27].  It also adequately describes three extreme cases of capsule dissolution processes.  
In addition, the simulated profile using the theoretical mass transfer coefficient of 0.29 
mm/min correlates well with the experimental data.  This similarity between the two 
profiles is validated using statistical analysis.  
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CHAPTER SEVEN                                                                                       
CONCLUSION AND FUTURE WORK 
 
In conclusion, a mathematical model that combines the mass transfer principles 
and the hydrodynamic effect within the USP Apparatus II was developed and validated to 
describe capsule dissolution.  The simulated profiles show that the CFD-predicted 
tangential velocities can be used to estimate the mass transfer coefficient, as suggested in 
the literature [17].  The simulation results and the estimated mass transfer coefficient 
show that the dissolution rate changes as a function of capsule location.  An off-centered 
capsule has a much faster dissolution profile than a centrally located capsule.  This is 
consistent with the observations reported in the literature [9, 10, 15-19, 21, 24, 25, 27].  
In addition, the model shows that the slug size affects the dissolution profile.    
The current model not only simulates the capsule dissolution profile, it also 
provides insight as to the dissolution mechanism.  For example, the model can determine 
whether a drug product disintegrates or erodes during dissolution testing.  The model 
correctly simulates the trend for three extreme dissolution processes.  It can also suggest 
if the dissolution is dominated by disintegration or erosion process should both processes 
be present in the system.  
Finally, the model shows that the Markov chain can be applied to model particles 
breakage and their population distribution during the dissolution process.  The particle 
breakage coefficient, the slug breakage coefficient, and the mass transfer coefficient 
should all be carefully selected to correctly describe capsule dissolution.   
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 In this study, the mass transfer coefficient was assumed to be constant during the 
dissolution process.  To further improve the model, the change in mass transfer 
coefficient as a function of time, slug surface area, and particle size area should be 
investigated in future studies. 
 In addition to the prediction of the experimental dissolution profile, the simulated 
profiles are shown to correctly predict the dissolution profiles for a pure erosion process, 
a fast disintegration process, and a pure disintegration process without diffusion.  Actual 
capsule dissolution experiments should be conducted in the future to verify the accuracy 
of these dissolution profiles. 
Lastly, the slug and particle breakage coefficients are not random numbers that 
can be conveniently modified such that the simulated profile matches the experimental 
data.  These two coefficients, similar to the mass transfer coefficient, technically consist 
of a group of the slug properties, particle properties, and the dissolution system 
properties.  The slug breakage coefficient should actually consist of the tangential 
velocity and the density of the slug.  Since these two are properties with known values, 
they were pulled out of the slug breakage coefficient and presented as part of the 
coefficient of time inside the exponential term in Equation 14.  However, there should be 
many more factors besides these two that determine the slug breakage coefficient.  Slug 
and particle breakage coefficients estimation are definitely worth looking into for future 
studies. 
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APPENDIX A                                                                                          
ESTIMATION OF TANGENTIAL VELOCITY  
 
Tangential velocity estimation from Bai et al. [24] 
The y-axis of the tangential velocity profiles presented by Bai et al. [24] 
represents the tangential velocity normalized to the impeller tip speed, and the x-axis is 
the radial distance presented as 2r/T, where r is the radial distance from the center of the 
shaft and T is the vessel diameter with a length of 100.16 mm.  Given the values for 2r/T 
from the x-axis of the graphs presented by Bai et al. [24], the radial distance from the 
center of the shaft can be determined.  Table A-1 presents the computed results for r 
when 2r/T is equal to 0.1 and 0.2.  
Table A-1.  Determination of the radial distance from the center of the shaft. 
 
2r/T r (mm) 
0.1 5.008 
0.2 10.016 
 
 Similarly, tangential velocities, vθ, can be estimated from the y-axis of the graph 
presented by Bai et al. [24].  Given the values for vθ / vtip from the y-axis, where vtip is the 
impeller tip speed (0.194 m/s), vθ can be determined.  Tangential velocities at three 
different locations of iso-surface planes (z = -31.75 mm, z = -37.75 mm, and z = -43.75 
mm), where z = 0 represents the intersection between the cylindrical and hemispherical 
sections of the vessel located 50.8 mm from the bottom of the vessel, were estimated and 
presented in Table A-2.  In addition, the corresponding distance from the bottom of the 
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vessel for the three locations were calculated by subtracting the absolute value of the 
vertical location of the iso-surface, z, from 50.8 mm.  These are presented in Table A-2. 
Table A-2.  Tangential velocities at various locations of the vessel. 
 
z (mm) 
Distance from 
vessel bottom 
(mm) 
 
r (mm) 
5.008 10.016 
-31.75 19.05 vθ / vtip 0.15 0.3 
vθ (m/s) 0.029 0.058 
-37.75 13.05 vθ / vtip 0.16 0.3 
vθ (m/s) 0.031 0.058 
-43.75 7.05 vθ / vtip 0.15 0.29 
vθ (m/s) 0.029 0.056 
 
Tangential velocity estimation from McCarthy et al. [25] 
  McCarthy et al. [25] graphically presented the CFD-predicted tangential 
velocities for four radial positions on an iso-surface plane 5.3 mm from the bottom of the 
vessel.  These four radial positions are named R = 0.094, R = 0.177, R = 0.262, and R = 
0.344, where R is the ratio of the actual radius, r, to the radius of the cylindrical part of 
the vessel (rw = 50.8 mm).  Therefore, a value of R = 0.094 corresponds to an actual 
radius, r, of 0.094 * 50.8 mm = 4.7752 mm.   
 The tangential velocities at each of these four radial positions can be determined 
from the graph presented by McCarthy et al. [25].  The ratio of tangential velocity to 
paddle tip speed was approximated from the y-axis of the graph for each radial position.  
The tangential velocity can therefore be estimated by multiplying that ratio by the tip 
speed (0.196 m/s).  For example, the average ratio of tangential velocity to paddle tip 
speed at R = 0.094 was about 0.15.  Therefore, tangential velocity at r = 4.78 mm is 
estimated to be 0.15 * 0.196 m/s = 0.0294 m/s.  Table A-3 presents the actual radial 
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positions, r, as well as their tangential velocities corresponding to the four normalized 
radial positions, R. 
Table A-3.  Tangential velocities at various radial positions in the vessel.  
 
R r (mm) vθ / vtip vθ (m/s) 
0.094 4.78 0.15 0.029 
0.177 8.99 0.25 0.049 
0.262 13.31 0.35 0.069 
0.344 17.48 0.45 0.088 
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APPENDIX B                                                                                                
CUMULATIVE PARTICLE SIZE DISTRIBUTION DETERMINATION 
  
Table B-1 and Figure B-1 present the cumulative percentage of ascorbic acid 
particle size distribution measured by Heda et al. [45].  Using the equation of the trend 
line from Figure B-1, the cumulative percentage of ascorbic acid particle size distribution 
at various sizes could be determined.  The result of seven discrete particle sizes is 
presented in Table B-2.  In addition, the cumulative percentage was normalized to 100%, 
and the net percentage of each size was also estimated. 
Table B-1.  Cumulative percentage of ascorbic acid particle size distribution. 
Size (µm) Cumulative percentage 
74 100 
88 98 
125 93 
177 85 
250 70 
590 8 
 
 
Figure B-1.  Cumulative percent lots of ascorbic acid particle size distribution. 
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Table B-2.  Cumulative and net percentage of ascorbic acid particle size distribution. 
Size (µm) 
Cumulative 
percentage 
(predicted) 
Cumulative 
percentage 
(normalized) 
Net percentage 
74 101 100 15 
160 86 85 16 
246 70 69 15 
332 55 54 15 
418 39 39 15 
504 24 24 16 
590 9 8 8 
 
Table B-3 presents the resulting state probability, ai, for each of the seven state, i, 
with diameter xi at time tb = t0 as well as the lower limit, di-1, and upper limit, di, of state 
interval i. 
Table B-3.  The state probability for particles with diameter, xi, at time t0 and the limit of 
state interval i. 
 
i xi (µm) ai di-1 di 
1 74 0.15 31 117 
2 160 0.16 117 203 
3 246 0.15 203 289 
4 332 0.15 289 375 
5 418 0.15 375 461 
6 504 0.16 461 547 
7 590 0.08 547 633 
 
 
 
 
 
 
 
 
 
 
 
 
92 
APPENDIX C                                                                                                  
DERIVATION OF EXPERIMENTAL MASS TRANSFER COEFFICIENT 
  
A cylindrical slug is defined to have initial diameter, dSl0, and initial length, LSl0.  
Assume the slug erodes throughout the dissolution test such that the ratio of length to 
diameter remains constant during dissolution testing, β can be defined as Equation C-1. 
The surface area, ASl, and the volume, VSl, of the cylindrical slug can therefore be 
expressed as Equations C-2 and C-3, respectively. 
                                                                
β =
LSl
dSl
                                            Equation C-1 
                                                         
ASl = πdSl2
1+ 2β
2
 
 
 
 
 
                                     Equation C-2 
                                                              VSl =
βπdSl3
4
                                         Equation C-3 
 From mass balance, a decrease in mass from the solid slug should result in an 
increase in drug concentration in the medium.  This is presented by Equation C-4. 
                                                    
ρSl VSl0 −VSl( )
VL
= C − C0                                Equation C-4 
 Assume the density of the slug is constant and substitute Equation C-3 into 
Equation C-4, an expression for the slug diameter, dSl, can be obtained, as shown in 
Equation C-5.  Equation C-2 and Equation C-5 together give Equation C-6.  Incorporate 
Equation C-6 into Equation 3 and integrate the equation gives Equation 46.  The 
experimental mass transfer coefficient is obtained by integrating Equation 46 from zero 
to 40 minutes using Excel™. 
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APPENDIX D                                                                                          
MARKOV CHAIN 
 
 
With α having a value of 10-10 µm-3s-1 and τ equals to 30 seconds, the calculated 
values for the matrices, D, L, and P, are presented by Equations D-1, D-2, and D-3, 
respectively.  The state probability vector, a(t), was estimated and the graph showing a(t) 
for particle size distribution from zero to 60 minutes is presented in Figure D-1. 
                            
D =
1 0 0 0 0 0 0
0 0.988 0 0 0 0 0
0 0 0.955 0 0 0 0
0 0 0 0.890 0 0 0
0 0 0 0 0.781 0 0
0 0 0 0 0 0.616 0
0 0 0 0 0 0 0.384
       Equation D-1 
                           
L =
0 0 0 0 0 0 0
0.024 0 0 0 0 0 0
0.017 0.072 0 0 0 0 0
0.014 0.062 0.143 0 0 0 0
0.013 0.056 0.131 0.238 0 0 0
0.012 0.053 0.124 0.224 0.355 0 0
0.012 0.051 0.119 0.215 0.341 0.495 0
       Equation D-2 
                        
P =
1 0 0 0 0 0 0
0.024 0.988 0 0 0 0 0
0.017 0.072 0.955 0 0 0 0
0.014 0.062 0.143 0.890 0 0 0
0.013 0.056 0.131 0.238 0.781 0 0
0.012 0.053 0.124 0.224 0.355 0.616 0
0.012 0.051 0.119 0.215 0.341 0.495 0.384
    Equation D-3 
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Figure D-1.  Particle size distribution from zero to 60 minutes. 
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APPENDIX E                                                                                          
VARIABLES FOR MASS TRANSFER COEFFICIENT ESTIMATION 
 
 
Table E-1 reports the values of the properties of the dissolution medium and 
ascorbic acid used in determining the theoretical mass transfer coefficient. 
Table E-1.  Properties of dissolution medium and ascorbic acid used in ktheo estimation 
where vθ = 2640 mm/min. 
 
Properties Values Notes 
dSl0 (mm) 6.3 Slug diameter 
LSl0 (mm) 16.46 Slug length 
vθ (mm/min) 2640 n/a 
ρ (g/mm3) 0.001 Water 
µ (g/mm min) 0.042 Water 
Re 715 Dissolution system 
ψB 2.6 Water 
M (g/mol) 18.02 Water 
TK (K) 310 Water 
MAC (g/mol) 176.13 Ascorbic acid 
ρAC (g/cm3) 1.65 Ascorbic acid 
VA (cm3/mol) 106.7 Ascorbic acid 
DAB (mm2/min) 0.0572 Ascorbic acid/water 
Sc 735 Dissolution system 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
